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Abstract
According to the World Health Organization, up to 50% of type 2 diabetic patients
develop neuropathy, which may cause major infections, amputation, and Charcot foot due
to impaired sensation. Early recognition and care is essential for treatment of Charcot
foot and prevention of further injury. Due to the complexity of this potentially lifethreatening complication, assessment is challenging, especially when practitioners who
treat adult diabetic patients may not be familiar with Charcot foot. The purpose of this
scholarly project was to develop an assessment, screening tool, and algorithm for
detecting Charcot foot; an additional goal was to develop practice guidelines for
practitioners to assist in the early recognition, treatment, and referral of adult diabetic
patients at risk for Charcot foot. Lippitt’s theory of change was used to guide the project.
An interdisciplinary team of stakeholders was assembled to guide development of the
tool, algorithm, and practice guidelines. Products were developed in accordance with
evidence in current peer-reviewed literature and American Diabetes Association
recommendations for Charcot foot diagnosis, treatment, and referral. Content was
validated using a scale content validation instrument process to obtain input from experts
in the care of Charcot foot. An implementation plan was developed to guide introduction
of the products into practice, and an evaluation plan created to determine the extent to
which intermediate term outcomes are met using these products. The project may
contribute to social change by identifying patients at risk for Charcot foot prior to the
onset of the complication, therefore preventing further injury, deformity, or amputation in
populations that are often unable to afford quality healthcare.
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Section 1: Overview of the Evidence-Based Project
Introduction
According to the World Health Organization (WHO), approximately 347 million
people worldwide have type 2 diabetes, and in 2004, it was estimated that 3.4 million
people died as a result of complications from high fasting blood sugar (WHO, 2013). The
WHO projects that the 7th leading cause of death in 2030 will be a direct result of
diabetes (WHO, 2013). Maintaining a healthy diet, a normal body weight, avoiding
tobacco use, and incorporating regular physical activity can prevent or delay the onset of
type 2 diabetes. According to National Diabetes Information Clearinghouse (NDIC),
diabetes is the seventh leading cause of death in the U.S. and affects millions of
Americans (NDIC, 2011). The virulence of diabetes and its prevalence has steadily
increased over the years and continues to rise. Fowler (2007) reports that diabetes has
become a major cause of morbidity and mortality in the United States, which also
continue to increase globally each year. “The magnitude of current statistics indicates that
diabetes will continue to affect the United States population for the foreseeable future and
is by no means limited to the United States” (Fowler, 2007, para. 5). Of the millions of
Americans who are diagnosed every year, the number of those who go undiagnosed is
even greater, meaning everyone should observe the warning signs and have routine
screenings completed. Type 2 diabetes is a devastating chronic disease with the potential
to have life-long effects to all major organs including kidneys, heart, eyes, and blood
vessels. The American Diabetes Association (ADA) reports that type 2 diabetes produces
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severe systemic complications such as nephropathy, neuropathy, retinopathy, foot
complications, heart disease, stroke and many other devastating health problems, which
occur due to uncontrolled elevated glycemic levels (ADA 2013). Maintaining controlled
blood sugar levels can help prevent these complications.
Problem Statement
Diabetic neuropathy is the most prevalent complication of type 2 diabetes,
affecting up to 50% of all diabetic patients (WHO, 2016). Peripheral neuropathy,
meaning peripheral nerve damage, causes significant issues such as nonhealing wounds,
major infections, and amputations. Another consequence of peripheral neuropathy can be
Charcot neuropathic osteoarthropathy (CN), commonly referred to as Charcot foot, which
involves the soft tissue and bones of the foot and ankle and leads to permanent
deformities. This condition may ensue if the bones in the feet suffer fractures and the foot
becomes misaligned. Although experiencing a fracture would be extremely painful to
most people, this particular condition can be painless to the diabetic patient due to nerve
damage from diabetes prior to the fracture. The foot may eventually lose muscle support,
leading to deformity. Diagnosis can sometimes be difficult due to the potential
mimicking of other conditions such as deep venous thrombosis or cellulitis; therefore,
diagnosis of a Charcot fracture cannot be made definitively until bone changes occur. The
problem identified and addressed in the project is inconsistency by healthcare providers
in the recognition and referral of patients with potential Charcot foot.
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Purpose Statement
According to Lin and Lorenzo (2013, para. 2), “in type 1 DM, distal
polyneuropathy typically becomes symptomatic after many years of chronic prolonged
hyperglycemia, whereas in type 2, it may be apparent after only a few years of known
poor glycemic control or even at diagnosis.” Symptoms affect sensory, motor, and
autonomic systems of the body. When neuropathy progresses to Charcot foot, it becomes
a serious, potentially limb-threatening complication and during the acute phase, is
considered to be an inflammatory syndrome. Due to the rarity of this condition, diagnosis
and treatment pose a critical issue for healthcare practitioners including nurse
practitioners (Rogers et al, 2011). The purpose of the project was the development of an
assessment and screening tool for nurse practitioners providing care for type 2 diabetics
at risk of Charcot foot, and integration of ADA Charcot diagnosis and treatment
recommendations for nurse practitioners to assist in the early recognition and treatment of
Charcot foot with the goal of preventing further complications and possible loss of the
foot or more of the lower extremity.
Goals and Objectives
The purpose of this project was to develop an assessment and screening tool and
incorporate recommendations set forth by the ADA in an effort to assist healthcare
practitioners in early recognition, diagnosis, and treatment of Charcot foot in the diabetic
patient with peripheral neuropathy. In doing so, the goal was to improve consistency in

4
the diagnosis and treatment by healthcare providers of patients with or at risk of Charcot
foot.
In this section, I outline the process by which an assessment tool was developed
as well as discuss its implementation and evaluation. No data was collected nor were
participants involved as the project involved the development of an assessment tool to
further assist nurse practitioners (NPs) in the early detection, identification, and treatment
of type 2 diabetic patients at risk of Charcot foot.
The outcomes that were used to determine goal attainment for the project included
an evaluation planning step at the end of this DNP Project. The following outcomes were
initially suggested as possible starting points for evaluation planning:
Outcome 1: Healthcare providers will identify, assess, and treat patients with
Charcot foot.
Outcome 2: Healthcare providers will refer patients with Charcot foot to
appropriate specialty for follow up care.
The detection of patient risks by nurses, which is “the ability of nurses to
accurately identify signals can lead to early interventions so that harm to patients is
minimized or circumvented” (Despins, Scott-Cawiezell, & Rouder, 2010, p. 465). Nurses
and nurse practitioners are at the forefront of patient assessment, which is the first
opportunity for detection and intervention of potentially life-threatening illness and
injuries. They have a responsibility to patients to be skilled in their assessment abilities
and intervene when necessary. Charcot foot, although complex and often difficult to
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diagnose, is a major complication of diabetes that requires immediate treatment after a
detailed and skilled assessment by competent healthcare professionals.
Significance of the Project
The American Diabetes Association has developed guidelines for all healthcare
practitioners to follow regarding the diagnosis, treatment, and surgical intervention of
Charcot foot with the goal of rapid identification of signs and symptoms and appropriate
treatment regimens as a means of preventing further complications. Currently, there are
no exclusive assessment and screening tools and treatment algorithms specifically for
NPs that address the patient at risk of Charcot foot. The project tools will meet the
guidelines set forth by the ADA.
Implications for Social Change of Practice
Accurate assessment of the diabetic foot is a complex process requiring skill,
experience, and knowledge of not only the disease but also signs and symptoms of
potential complications. The loss of sensation due to peripheral nerve damage makes it
difficult for patients to help providers diagnose developing problems. They often present
with vague symptoms or nonhealing wounds and often unaware of the nature of the initial
injury. This is exacerbated by the unseen nature of problematic internal changes such as
destruction of bone tissue and cartilage as a result of uncontrolled hyperglycemia. It is
crucial that diabetic patients are consistently and closely monitored and made aware of
the potential complications associated with the disease. According to Meyers (2013), by
decreasing the incidence of amputations and improving quality of life through education
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and close monitoring, the result will be a decrease in the amount of funds spent long-term
for care of the patient with diabetes. However, many clinicians lack experience in the
area of Charcot foot assessment and often consider it as simply “a diabetic foot.”

Figure 1. Why does Charcot deformity happen? (Perez, 2014)
According to Zgonis (2010), there is a limited amount of scientific literature in
regard to treatment protocols and guidelines for management of Charcot foot and ankle
deformities and may be in part due to the vague presentation of each individual case.
Although many patients present with obvious deformities, there are a higher number of
those who have few or vague complaints, which adds to the difficulty of accurate
diagnosis for the practitioner.
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Definition of Terms
The principal terms used throughout this project will be:
Type 2 Diabetes: Type 2 is the most common type of diabetes and is defined as a
condition in which the body does not properly utilize insulin. This is also referred to as
insulin resistance. Typically, the pancreas produces an excess of insulin to accommodate
elevated blood glucose levels; however, over time it is unable to adequately keep up with
the body’s demand of insulin to maintain normal blood glucose levels (ADA,
n.d.).Peripheral neuropathy: Peripheral neuropathy refers to the destruction or
dysfunction of peripheral nerves, which are damaged by uncontrolled elevated blood
glucose levels, infection, trauma, metabolic disturbances, and exposure to toxins (Mayo
Clinic, n.d.). Charcot foot: Charcot-Marie-Tooth (Charcot foot or CMT) was first defined
in 1886 by three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry
Tooth (Charcot-Marie-Tooth Association [CMTA], 2010). It is a serious and potentially
life-threatening complication of diabetes, which is characterized by various degrees of
bone, joint, soft tissue, foot and often ankle involvement due to underlying neuropathy,
trauma, and perturbations of bone metabolism, and it involves inflammation during the
acute phase (Rogers et al, 2011).
Podiatric: Podiatric refers to the specialty of a physician who is a doctor of
podiatric medicine (DPM), also known as a podiatric surgeon or physician who diagnoses
and treats conditions of the foot, ankle, and related structures of the leg (American
Podiatric Medical Association [APMA], 2014). Acute: Acute means a condition
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characterized by sharpness or severity or having a sudden onset or short course or
requiring short-term medical care for serious illness or traumatic injury (acute, 2014).
Inflammatory: Inflammatory refers to the body's response to either invading
foreign substances (such as viruses or bacteria) or to direct injury of body tissue
(inflammatory, 2014).
Deformity: Deformity is defined as the quality or state of being deformed,
disfigured, or misshapen (deformity, 2014).
Amputation: Amputation is the accidental or intentional removal of a limb or
body part (“amputation”, 2014).

Limitations
A limitation of this project could be the willingness of all stakeholders to
participate in the change. The effectiveness and success of a program relies heavily on
the readiness of interested parties to be actively engaged and ready for change.
Stakeholders can help (or hinder) an evaluation before it is conducted, while it is being
conducted, and after the results are collected and ready for use. “Stakeholders are much
more likely to support the evaluation and act on the results and recommendations if they
are involved in the evaluation process” (George, Daniel, Frankish, Herbert & Bowie, n.d.,
p. 14). The identified stakeholders for this project included health practitioners who are
completing the diabetic foot assessment.
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Relevance to Nursing Practice
Due to the fact that type 2 diabetics are at risk for numerous multisystem
complications, all healthcare personnel, including nurse practitioners, have a
responsibility to patients to be knowledgeable and competent in advanced assessment
skills in hopes of preventing further complications. According to Rogers et al (2011, p.
2123), “the Charcot foot in diabetes poses many clinical challenges in its diagnosis and
management. Despite the time that has passed since the first publication on pedal
osteoarthropathy in 1883, we have much to learn about the pathophysiology, and little
evidence exists on treatments of this disorder.” Identification of Charcot foot in its early
stages is crucial to successful treatment. Patients should be referred to a podiatric
specialist at the first indication or onset of symptoms. Diagnosis may often be
challenging, mimicking of other major conditions such as cellulitis or deep venous
thrombosis, since diagnosis of a Charcot fracture is unable to be definitively made until
bone changes occur. The initial clinical manifestations of Charcot foot are frequently
mild in nature; however, they can become more pronounced with repetitive trauma.
Worsening usually occurs slowly with age and rapid progression is rare but warrants a
prompt re-evaluation. Since undiagnosed Charcot can lead to serious complications
including infection, deformity, amputations, disability, loss of employment, financial and
mental strains, and life-long devastating effects, it is crucial for practitioners to be
knowledgeable and skilled in assessment and treatment methods.
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Summary
This chapter described the significance and relevance of a competent and skilled
foot assessment for all type 2 diabetics suffering from impaired sensory and are at risk for
the development of Charcot foot. Lack of knowledge may contribute to undiagnosed
cases of Charcot and therefore place patients at risk of further complications. An
assessment tool could assist healthcare providers in rapidly identifying the signs and
symptoms of Charcot and determining the appropriate treatment or referral to a podiatry
specialist.
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Section 2: Review of Literature and Theoretical and Conceptual Framework
Introduction
The purpose of this project was to develop an assessment and screening tool for
nurse practitioners to assist in the early recognition, diagnosis, and treatment of Charcot
foot in type 2 diabetic patients. The goal was to determine appropriate treatment or
referral to a podiatric specialist for further evaluation and treatment in order to prevent
further complications, including loss of limb,. This section will examine literature
regarding the effects of untreated Charcot foot as well as appropriate treatment methods.
Literature Search Strategy
The literature search was electronically conducted and used the following
databases: CINAHL, Medline, PubMed, EBSCO, and Walden University Library.
Articles older than 10 years were not considered. The terms used for the search were:
diabetes, type 2 diabetes, diabetes statistics, neuropathy, peripheral neuropathy, diabetic
complications, Charcot, Charcot foot, Charcot-Marie-Tooth, podiatry, podiatric,
orthopedic complications, foot deformities, diabetic assessment forms, foot assessment,
and peripheral neuropathy assessment.
Literature Review
“Charcot neuroarthropathy is an often overlooked complication in diabetic
patients with peripheral neuropathy. A group of experts reported that 25% of patients
referred to their facility who had Charcot neuroarthropathy had not received a correct
diagnosis at the referring institution. The incorrect diagnoses included infection, gout,
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arthritis, fracture, venous insufficiency, and tumor” (Botek, Anderson & Taylor, 2010, p.
596). Botek et al. (2010) focused in detail on the devastating effects of misdiagnosed
Charcot and emphasized the importance of accurate assessment by healthcare providers.
The authors also discussed a case in which a 53 year-old male presented to the
emergency department with a 3 day history of redness, pain, and swelling to the foot and
ankle and was misdiagnosed with cellulitis, admitted to the hospital for a course of
antibiotics, discharged home with oral antibiotics, seen at his primary healthcare
providers office 2-3 more times for follow up, then finally referred to an orthopedic
specialist where he was accurately diagnosed with Charcot foot in the acute phase. By
this time, there was irreversible extensive damage to the foot.
According to O’Rourke (2010), from 1999-2008, of patients who underwent
either a below or above the knee amputation, 60% suffered from diabetic neuropathy and
had some type of trauma, nonhealing wound, or other complication such as Charcot foot.
Centered from a thorough review and analysis of the study, the primary issue for patients
at high risk of ankle and foot problems was the identification and referral to the
appropriate specialist (O’Rourke, 2010). Healthcare professionals, including nurse
practitioners, were among those who did not recognize potential issues, which delayed
care and led to amputations of the 3,445 patients included in the study.
Symptoms of Charcot foot affect sensory, motor, and autonomic systems of the
body. When neuropathy progresses to Charcot arthropathy, it becomes a serious, potential
limb-threatening complication and during the acute phase is considered to be an
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inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment pose
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al,
2011). Therefore, an assessment and screening tool for nurse practitioners is needed to
assist in the recognition, diagnosis, and treatment of Charcot foot in order to prevent
further injury and possible loss of foot or lower extremity.
Mumoli & Camaiti (2012) discussed a case of Charcot in the Canadian Journal of
Medicine in which a 59 year-old male with complaints of a plantar ulcer for two months
presented to his healthcare provider’s office. However, after examination, his healthcare
provider discovered that his foot was also deformed. The finding was that the patient had
such severe neuropathy that he felt no pain at all. They go on to state early detection is
essential and “prevention of disease progression remains the mainstay of treatment,
including prompt immobilization, absolute non-weight-bearing and professional foot care
on a regular basis” (p. 1392). While even the slightest of infection, injury, or minor
surgery may trigger the body’s inflammatory response, without the protective barrier of
pain being present, diabetic patients with sensory impairment are at greater risk of further
injury, and early recognition is crucial (Kaynak, Birsel, Guven & Ogut, 2013).
Another valid argument derives from a literature review by Milne et al. (2013),
which discussed suggestions to assist healthcare providers in making early diagnoses of
Charcot foot, choosing the appropriate treatment regimen, and reducing the incidence of
further complications including amputations, sepsis and death. “Charcot neuroarthropathy
(CN) continues to be a persistent challenge for clinicians, especially in its acute phase.
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The report indicated that the diagnosis of CN is missed in as many as 79% of cases and
an accurate diagnosis can be delayed up to 29 weeks” (p. 9).
According to Gouveri & Papanas (2011), accurate diagnosis of Charcot can often
be challenging. The authors stress the significance of patient and physician awareness as
a means to obtain a prompt diagnosis and reduce the incidence of foot complications.
“Charcot arthroneuropathy is a potentially limb-threatening condition which, beyond the
emotional and social burden of physical dysfunction, has been associated with increased
mortality” (Gouveri & Papanas, 2011, p. 59). In addition, the article contains five
practical point recommendations for clinicians to aid them in early detection and
management. They include:


Charcot should be ruled out in every diabetic patient with impaired sensory
perception, regardless if the diagnosis is only a suspicion.



Immediate off-loading is recommended; if plain x-rays are negative, this
should not delay off-loading.



Patient and physician education regarding early detection is essential.



Ulceration or infection in the plantar aspect of the foot should be avoided and
if surgical intervention is required, a podiatric specialist should be consulted.



A detailed foot assessment and documentation utilizing a specified assessment
tool, which follows ADA guidelines by a skilled practitioner, is recommended
for all diabetic patients.
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Finally, according to Jackson (2011), many diabetic patients with existing
neuropathy may present with other distracting issues such as foot ulcerations, swollen
extremities, or have no complaints of pain or discomfort at all; however, clinicians still
have the responsibility to perform a thorough examination of the diabetic foot and must
be skilled in their assessment techniques. Most complications of Charcot can be avoided
with immediate treatment in the acute phase. While it is equally important to exclude
other infectious processes or conditions such as deep vein thrombosis (DVT), “the
overriding goal of treatment is to avoid amputation and prevent further deformity. Good
outcomes can be managed with footwear that allows adequate gait and activity, thus
sustaining overall quality of life” (Jackson, 2011, para. 21).
Evidence-Based Practice Model
The need for an assessment and screening tool for nurse practitioners, based on
the increased risk of Charcot foot in the diabetic patient population, is an example of the
Iowa model of evidence-based practice. This model begins with a trigger or identified
problem, which may also be a knowledge-based problem. It involves the development of
a team of stakeholders to develop, implement, and evaluate a practice change (Malone &
Bucknall, 2013, 139).
The Iowa model for evidence-based practice includes knowledge and problem
triggers, which prompt providers to evaluate current practices as well as promote research
when evidence is lacking (Rempher, 2006). “The Iowa Model of Research in Practice
infuses research into practice to improve the quality of care, and is an outgrowth of the
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Quality Assurance Model Using Research (QAMUR). Research utilization is seen as an
organizational process. Planned change principles are used to integrate research and
practice. The model integrates evidence-based healthcare acknowledges and uses a
multidisciplinary team approach” (Mercy Medical Center, 2014, para. 8).
According to a study by Varaei, Salsali & Heshmat (2013), the Iowa model was
followed in a before and after design and involving 19 baccalaureate nurses who were
currently working on an endocrinology unit in which the primary patient population
consisted of diabetics with chronic leg ulcers. The focus of the study was whether
evidence-based practice training courses could improve nursing skills. Results indicated
trained nurses can prevent significant complications in diabetic patients including
amputations and other adverse effects by means of early recognition and treatment
interventions.
This model has served as a reference for the project since the primary goal is
directed at improving patient health and outcomes by identifying a trigger such as
misdiagnosed Charcot foot, then integrating a multidisciplinary team to design an
improvement plan such as assessment tool development and review of ADA policy and
practice guidelines. “In this model, knowledge- and problem-focused triggers lead staff
members to question current nursing practice and whether patient care can be improved
through the use of research findings” (Titler & Moore, 2010, p. S3). Putting evidence into
practice can be a complex process, but it is necessary for improvements in healthcare and
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patient outcomes. The Iowa model has been a valuable resource in the project by
providing a systematic process to identify and address an issue in diabetic health.
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Figure 2. Iowa model of evidence-based practice
Prevalence and Incidence
The American Diabetes Association reports that approximately 60–70% of people
with diabetes will develop peripheral nerve damage, which can lead to Charcot foot with
an estimated 0.5% of those patients actually developing the condition. In most cases, the
onset occurs after the age of 50 and in those patients who have been diagnosed for 15 to
20 years (Peng & Swierzerswki, 2011).
Despite the fact that uncontrolled diabetes and loss of proprioception is the main
contributing factor leading to Charcot, researchers now believe other predisposing
elements may increase the risk such as widespread atherosclerosis, inflammation caused
by minor injury, infection, ulceration, or any other disorder in which blood flow is
impeded (Kaynak et al., 2013). Discovering the underlying etiology is a crucial aspect in
successful treatment.
The incidence and prevalence of Charcot is not known exactly but is estimated
that approximately 0.8-8% of the diabetic population are affected. The number is
increased up to 10% when radiographic studies are used in diabetics with neuropathy. In
addition, studies have shown men and women are equally affected and typically have had
diabetes for at least 10 years and are between the ages of 50-70 (Gouveri & Papanas,
2011).
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Impact of Charcot Foot
Charcot is a devastating complication of diabetic peripheral neuropathy and not
only may affect a person’s physical appearance and their ability to work; it also has the
potential of having a significant effect on their mental capabilities. Patients are often left
with feelings of depression, guilt from financial strains, and isolation. In addition,
patients suffering from Charcot experience a high rate of depression and anxiety due to
physical mobility restraints and chronic pain. Male patients are even more at risk of
complications due to an inability to work and provide for their families financially
(Chapman, Shuttleworth & Huber, 2014).
Finally, studies show that mortality rates of individuals with Charcot foot are
significantly higher than those who have simple diabetic foot ulcerations and also those
with type 2 diabetes not suffering foot complications at all. The comparable rates are
28.3, 37.0, and 18.8% (Sohn, Lee, Stuck, Frykberg & Budiman-Mak, 2009).
Risk Factors
There are a variety of risks factors associated with the development of Charcot
arthropathy and occur in patients with peripheral neuropathy resulting from diverse
conditions including diabetes mellitus, leprosy, syphilis, poliomyelitis, chronic
alcoholism or syringomyelia. Repetitive microtrauma that exceeds the rate of healing
may also cause fractures and dislocations as well as changes in circulation causing
resorption of bone, weakening the bone and increasing susceptibility to fracture and
dislocation” (American Orthopedic Foot & Ankle Society, n.d.). Other contributing
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factors may consist of sprains or other injury, which goes unnoticed as a result of sensory
impairment. Continued pressure on the foot while walking may worsen the extent of the
injury with subsequent dislocation or fractures in one or more bones of the foot or ankle.
Signs and Symptoms
Symptoms may include: foot deformity with elevated arch; foot drop, which is an
inability to hold the foot horizontal); “slapping" gait (feet slap on the floor when walking
due to foot drop); muscle atrophy in the lower extremities, leading to thin calves;
numbness in the feet; balance or gait instability; later, similar symptoms may also
develop in the arms and hands; joint dislocation; heat insensitivity in the foot; joint
instability; erythema; bounding pulses; edema of the foot and ankle (caused by leakage of
synovial fluid from the joint capsule); and subluxation (bone misalignment from a joint).
Complications
If left untreated or misdiagnosed, further serious complications may develop for
the patient and include the following: ulcerations, especially if foot deformity is present
or if there is a delay in diagnosis during early stages, calluses, bony protrusions (these
have a greater risk of infection if friction persists for an extended period on the inner
portion of the shoe), compression of blood vessels and/or nerves, osteomyelitis (bone
infection), impaired or loss of sensation in the foot, and loss of foot function.
Prevention
To effectively prevent the formation of Charcot, patients in the diabetic
population, or any person with peripheral neuropathy, should follow a strict foot regimen
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including daily inspection in an effort to reduce the incidence of foot, metatarsal, and
lower extremity amputation. This regimen consists of daily foot self-exams, wearing
closed toed shoes at all times, avoid going barefoot (even indoors), seeking medical
attention immediately if any open sores, injury, or changes to the appearance of the foot
or ankle, keeping feet clean and dry, and avoiding moisture. Referral is also a key
component in preventing Charcot. Patients considered being at high risk for developing
ulceration, infection, and Charcot arthropathy deformities should be referred to a group of
specialists who focus on mechanical, medical, and surgical intervention in the treatment
of the diabetic foot and lower extremity ("Charcot Foot | Charcot Foot Information |
Charcot Foot Treatment | Charcot Foot Prevention | Charcot Foot Symptoms," n.d.)
Treatment
Presently, there are numerous treatment methods available for treatment of
Charcot foot with the primary goal being joint stabilization. Although there are currently
no known treatments to stop or slow the progression of Charcot foot, research efforts
continue in hopes of finding a solution. Recovery period may extend upwards of eight
weeks or longer in the acute stage, during which time patients will be required to be nonweight-bearing. Treatment options for non-surgical interventions include:


Immobilization



Custom shoes and bracing



Use of crutches, casts, and wheelchair used to protect foot



Limiting activities that cause the condition
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Although surgical treatment is an option, treatment is primarily nonoperative due
to the added factor of diabetes associated poor wound healing. Conservative treatment of
Charcot foot relies on halting the destructive phase of progression, and then protecting
and supporting the joints throughout the healing process. Other activities to assist in
maintaining muscle strength include physical and occupational therapy, as well as
physical activity directed toward improving independent functioning. Treatment plans
can be broken into two phases, acute and post-acute. The acute treatment phase is
considered the onset until Charcot is inactive, which is 3-6 months after onset. Also,
immobilization is recommended to prevent further destruction. The goal in the treatment
of Charcot foot is intended to offload the foot, treat bone disease, and prevent further
injury. Offloading during the active acute stage of Charcot is the most crucial
management strategy and could prevent further progression to deformity, according to
ADA recommended guidelines.
American Diabetes Association Recommendations
Since Charcot foot in the diabetic patient poses many clinical diagnosis and
management challenges, the American Diabetes Association [ADA] task force met in
2011 and created recommendations for appropriately managing this devastating lower
extremity complication of diabetes, which is serious and potentially limb-threatening.
The ADA recommendations are based on expert opinion and are as follows. They are
available for access in Diabetes Care (Rogers et al, 2011).
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Diagnostic Recommendations for Active Charcot Foot
•

Diagnosis of active Charcot foot is based primarily on clinical assessment and
patient history but should be confirmed by imaging.

•

The earliest clinical manifestation is inflammation, which is an important
aspect in the pathophysiology of Charcot foot.

•

Despite absence of deformity, Charcot foot is considered to be acute and
active in sensory impaired individuals with foot or ankle fractures or
dislocations due to the inflammatory process of bone healing.

•

Initial radiologic imaging should be performed and healthcare providers are
urged to observe for subtle or underlying fractures or subluxations, regardless
of without obvious visible pathology.

•

Clinical suspicions may be confirmed with MRI or nuclear imaging in the
presence of normal-appearing radiographs.

Recommendations for Medical Therapy
•

Foot offloading and immobilization are the most vital treatment
recommendations in active Charcot foot and have the potential of preventing
further destruction.

•

Little evidence is available to guide in the use of available pharmacological
therapies to promote healing of Charcot foot.

•

Weight-bearing devices such as braces, prescription shoes, boots, or other
protective measures are required post active occurrence
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•

Lifetime monitoring is advised to monitor for diabetic foot complications or
recurrence or new signs of Charcot foot.
Summary

The severity of untreated or misdiagnosed Charcot foot can lead to potentially
life-threatening and or life changing complications. Patients are left with significant and
devastating alterations to their body and endure substantial financial costs. Individuals
with peripheral neuropathy have even higher rates of mortality than persons without
ulcerations than type 2 diabetics with intact peripheral sensation. Charcot is a major
health issue affecting an infinite number of patients each year, many of whom have never
heard of it and are unaware of its overwhelming and destructive potential. Prevention and
early detection are the keys to avoiding such effects.
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Section 3: Approach
Introduction
The purpose and goal of this quality improvement project was to develop an
assessment and screening tool to assist healthcare providers in the early detection,
diagnosis, and treatment of Charcot foot in the diabetic population. This project included
the target population of adult type 2 diabetic patients who have been diagnosed for at
least ten years, been treated with either oral hypoglycemic or insulin therapy, and either
have or are at risk of having peripheral neuropathy. Also included were those patients
with a history of or currently being treated for any type of foot ulceration, wound, injury,
or complaints of foot or ankle pain, and patients who have a documented change of foot
appearance. Stakeholders for this project were the patients, private insurance carriers,
Medicare and Medicaid, podiatrists, and healthcare practitioners who provide care to
diabetic patients. Accomplished project development activities are outlined as listed
below.
The steps in the process of this project were as follows:
1. Assemble interdisciplinary project team with various stakeholders guiding the
project;
2. review best practices of diabetic foot assessment as presented in evidencebased literature;
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3. integrate ADA policies and practice guidelines for the assessment, treatment,
and referral of the diabetic patient with, or at risk for developing, Charcot foot
in conjunction with the project team;
4. develop an assessment and screening tool of the diabetic foot in conjunction
with the project team;
5. develop an implementation plan in collaboration with the project team; and
6. develop an evaluation plan in collaboration with the project team.
Rationale
I assembled an interdisciplinary project team of community stakeholders
interested in supporting interventions to improve assessment and prevention of Charcot
foot in diabetic patients with peripheral neuropathy. Invited stakeholders included nurse
practitioners, diabetic educators, podiatrists, and health information specialists. A
literature review was conducted to identify current best practice on how to develop,
implement, and evaluate policy and practice guidelines, and this information was shared
with the project team. In addition, a meeting was conducted to inform members of the
Texas Panhandle Nurse Practitioners Group of the proposed project. During the meeting,
I solicited members of various clinics, such as medical directors, to participate in the
advisory group to support the creation and sustainment of the policies and guidelines.
From the project team and meeting, stakeholders were identified from various
groups to compose an advisory group, which aided in the development of an assessment
tool and its implementation and evaluation. “For a number of reasons, it is necessary to
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involve or consult with appropriate community members at the very beginning of the
program planning process and to include them on an advisory panel or planning
committee. As with the needs assessment process, target population and stakeholder
involvement is necessary during the planning and implementation stage” (Hodges &
Videto, 2011, p. 109).
Advisory committee members consist of individuals who offer expert skills and
unique knowledge, which strengthen the expertise of the board of directors as a means of
guiding the organization more effectively. They offer expert opinions and suggestions,
provide diversity, and offer fresh perspectives on programmatic issues (National
Abandoned Infants Advisory Resource Center, n.d.) One factor that facilitated the
development of an interdisciplinary team who supported the assessment and treatment of
Charcot foot was that of continuous community input via stakeholder engagement.
Stakeholder feedback and input is an integral part of any successful healthcare program.
Stakeholders offer valuable insight such as suggestions on plan development, and they
assist in setting strategic direction, goals, and performance targets (Curran & Totten,
2010). A review of the literature, in conjunction with feedback from project team
members, stakeholder input, and continued engagement through means of email follow
up and NP website discussion postings can increase the likelihood of program success.
Interdisciplinary Project Team
The multidisciplinary team consisting of five members was invited to participate
in the project based on their knowledge and expertise in the area of diabetes and
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management of complications. Disciplines included diabetes education, nurse
practitioner, podiatry, IT computer personnel, and nursing informatics. Members were
selected for their knowledge and experience in treating diabetic patients and their medical
specialty in podiatric medicine, computer technology, and informatics. Each member
reviewed the policy and practice guidelines regarding the early detection and intervention
of patients at risk of Charcot foot as well as appropriate treatment regimens. Utilization
of valid resources such as medical specialists and those having experience in one
particular area is beneficial for ensuring all essential elements are included in the plan
design. According to Nancarrow et al., (2013), interdisciplinary teamwork is “a dynamic
process involving two or more health professionals with complementary backgrounds and
skills, sharing common health goals and exercising concerted physical and mental effort
in assessing, planning, or evaluating patient care” (p. 2).
Reviewing Evidence
The interdisciplinary team members each received a copy of the goals and
objectives for the project prior to development of an assessment tool and were led
through the review of scholarly literature. Furthermore, a Gannt chart was dispersed to
each member to illustrate the incidence of Charcot foot along with information obtained
from the American Diabetes Association as well as the American Podiatric Medical
Association. All of the above was provided during an initial meeting with the
interdisciplinary team.
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Implementing Policies and Practice Guidelines
According to the 1992 Institute of Medicine (IOM) report, clinical practice
guidelines, are among the foundations in which to improve healthcare through
systematically developed statements that are meant to assist the practitioner, as well as
the patient, in decision-making regarding suitable healthcare for specific clinical
circumstances. This process involves problem identification, evidence assessment,
translation of the evidence, and implementation into clinical practice guidelines, followed
by evaluation and revision as necessary (Woolf, Schünemann, Eccles, Grimshaw &
Shekelle, 2012).
Charcot foot continues to be a complicated and complex diagnosis that remains a
clinical challenge for practitioners. As a result of the number of missed cases of Charcot
foot, in as many as 79%, most clinical guidelines available do not involve a rigorous
evidence-based process (Milne et al, 2013). Therefore, development of a screening tool
and algorithm will require input from multiple experts. Although not all diabetic foot
complications are preventable, it is possible to drastically lessen the incidence through
proper management and prevention platforms. “The multidisciplinary team approach to
diabetic foot disorders has been demonstrated as the optimal method to achieve favorable
rates of limb salvage in the high-risk diabetic patient” (Frykberg et al, 2006, p. S49).
Although there is no specific cure for Charcot foot, the goal in developing policy
and practice guidelines will be directed toward early detection, accurate diagnosis,
immediate initiation of treatment, and the referral process. Despite the fact that healthcare
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professionals are ultimately responsible for identifying patients at highest risk of Charcot
foot and completing an extensive and thorough assessment, the fact remains that patients
themselves are responsible for adhering to treatment regimens and following up with
referred specialists; for that reason, patients will be encouraged to be an active participant
in their care.
Content Validation
Content validation in the area of Charcot foot is essential in order to go forth with
the development of policy and practice guidelines. One method of validation is the
computation of a Scale Content Validation Instrument (S-CVI) with two expert raters for
a 10-Item scale, which is defined by Polit & Beck (2006) as the proportion of items given
a rating of quite/very relevant by both raters involved. This particular method allows the
entire scale of items, up to 10, to be ranked by the raters as valid and relevant by the two
experts and the proportion of total items judged content valid. Appendix A is an example
of this type of scale.
Implementation Plan
Following Internal Review Board (IRB) approval by Walden University, the
proposed assessment tool was developed by the project team for later implementation
with the nurse practitioner community in Northern Texas where there are currently 65
members of the Texas Panhandle Nurse Practitioners Association (TXPNPA). The
assessment tool was distributed only to practitioners who are the primary care giver of
adult type 2 diabetic patients. Part of the implementation phase included written forms of
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the assessment tool as well as the computerized version for those providers who have
converted to electronic documentation. One benefit of utilizing the electronic medical
record is the assessment tool will be a mandatory inclusion for providers, which will
serve as an assessment reminder and hopefully reduce the number of undiagnosed cases.
The computerized health information system being utilized at the health clinic has the
capability of revisions to assessment templates and will be maintained by the clinic’s
computer personnel. These plans were presented to the project team for consideration and
refinement. The final DNP Project included an implementation plan developed by the
project team.
Evaluation Plan
The evaluation plan development transpired after implementation planning and
was included as an appendix in the final DNP project paper. Evaluation was scheduled
after a 3-6 month assessment trial period to include key stakeholders of the project, nurse
practitioners in the Texas panhandle. The project team was the ultimate authority on
development of the evaluation plan and the following is the plan for evaluation that was
presented to the stakeholders as an integral part of this DNP project. The evaluation plan
for this project involved both a verbal and written formal process in the form of an
electronic anonymous survey. The focus of the evaluation was on the overall opinion of
the form as an effective means of assessment for the diabetic patient, ease of completing,
inclusion of pertinent focus areas, and appropriate referral documentation if needed.
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Financial Considerations
Budget is one of the most principal aspects to consider when developing a health
program. Finding the most appropriate resources for the target population often means
the planner must endure certain costs to ensure the highest quality services. Financial
considerations for this project included the utilization of resources such as computer
system IT personnel to load and maintain the EMR assessment tool. Each clinical setting
is equipped with computer equipment, which was in place prior to this project. For those
healthcare settings who do not have access to a computer based system, the financial
costs associated with this project were minimal and involved ordering of a paper form of
the assessment tool.
Ethical Considerations
Ethical considerations are essential for all members of the healthcare team. Nurses
have a responsibility to care for all patients, regardless of race, age, gender, national
origin, religion, or ability to pay for care. Diabetes is a serious health problem for many
Americans and affects a broad cultural diversity of individuals such as African
Americans, Asian and Pacific Islanders, American Indians, Hispanics, and Alaskan
Natives. Several of these individuals have little or no insurance coverage or access to
healthcare; therefore, are at an increased threat of acquiring problems such as Charcot
foot. Another issue is the cultural diversity of patients in today’s society. For these
reasons, ethical considerations for the development of an assessment tool included
awareness of healthcare providers in the areas of culture, financial, and even access to
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transportation. “The code of ethics for the American Association of Diabetic Educators
(AADE) urges diabetes educationalists to “respect and uphold basic human rights”, and
“respect the uniqueness, dignity, and autonomy of each individual” (“Cultural Sensitivity
and Diabetes Education”, 2012).
IRB approval ensuring that the project complied with the university’s ethical
standards and federal regulations was obtained from Walden University, IRB approval
number 02-20-15-0357309, and permission was given to move forward with the project
after an oral proposal defense.
Summary
Prevention of Charcot foot is an important aspect of assessment in the diabetic
population and more importantly, in patients suffering from peripheral neuropathy. The
ability to rapidly and accurately identify risk factors, signs and symptoms, and
appropriately treat this serious complication of diabetes is a significant measure in
preventing life-threatening injuries to patients’ feet and ankles. Following
recommendations set forth by the American Diabetes Association holds the responsibility
of every healthcare provider who cares for the diabetic patient and an accurate focused
assessment is a key factor of this care. Development of an assessment tool not only
assisted practitioners in this feat but has the potential to prevent devastating life-long
effects for the patient as well.
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Section 4: Findings, Discussion, and Implications
Introduction
While the project was developmental, no research was conducted, and it did not
include patient involvement. The purpose of this DNP scholarly project was to assist
nurse practitioners in the early detection, treatment, and referral of Charcot foot in type 2
diabetic patients. I developed an assessment and screening tool based on the American
Diabetes Association’s (2011) recommendations that could be utilized in the clinical
setting and integrated into the patient’s electronic medical record. In addition, a screening
algorithm and assessment and treatment practice guidelines were created for adjunct
purposes.
Focus points on the assessment were derived from key features of the foot, which
included monofilament points, evidence of outward physical abnormalities, and severity
of peripheral neuropathy. Monofilament testing, otherwise known as Semmes-Weinstein
monofilament exam, contains “5.07 monofilament nylon wires exert 10 g of force when
bowed into a C shape against the skin for 1 second. Patients who are unable to reliably
detect application of the 5.07, 10-g monofilament to designated sites on the plantar
surface of their feet are considered to have lost protective sensation” (Morgan, 2013,
para. 2). The assessment and screening tool also included a recommendation for annual
follow up or podiatric referral based on findings of the examination by way of a
screening algorithm. Finally, assessment and treatment practice guidelines were
developed to utilize at clinical or primary care sites.
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Summary and Evaluation of Findings
Due to the potential life threatening complications of type 2 diabetes and the
complexity in diagnosing Charcot foot, it is imperative that healthcare professionals, such
as nurse practitioners, be educated and competent in their assessment skills. According to
the U. S. Department of Health and Human Services Health Resources and Services
Administration Bureau of Health Professions Division of Nursing; (2002), “the adult
nurse practitioner employs evidence-based clinical practice guidelines to guide screening
activities, identifies health promotion needs, and provides anticipatory guidance and
counseling addressing environmental, lifestyle, and developmental issues” (p. 17).
Providers must maintain a degree of proficiency to support detect and treat all major
disease complications.
I presented the assessment and screening tool, assessment and treatment practice
guidelines, and screening algorithm to members of the Texas Panhandle Nurse
Practitioners Association at the Annual NP Conference, which included my practicum
mentor. Paper copies were dispersed during this time and members were allowed the
chance to ask questions and offer comments and suggestions immediately following.
There were several practitioners who voiced a need for clarification regarding
monofilament testing as well as a request to include the patient’s BMI on the assessment
tool; these suggestions were later included.
In addition, two content experts reviewed the tool using the Computation of an SCVI for a 10-Item Scale with Two Expert Raters (Appendix A). Content experts included
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a DNP-prepared nurse practitioner and a podiatrist. Revisions were made to the
assessment tool to include BMI and specific monofilament testing results. The final
revised assessment tool, screening algorithm, and practice guidelines are attached as
Appendices B, C, D, and E.
I have provided the practicum mentor with a final copy of each of the above
mentioned forms as well, which can be integrated into the electronic medical record for
use when screening the diabetic patient population at the practicum site.
Discussion of Findings in Context of Literature
After conducting an extensive literature search using databases such as CINAHL,
Medline, PubMed, EBSCO, and Walden University library, I discovered a need to
educate nurse practitioners as well as other healthcare providers in the severe and
conceivable life-threating complications of Charcot foot in the diabetic populace.
Through the use of evidence based practice, I identified the necessity for an assessment
and screening tool to contribute to the prevention and early detection of Charcot foot and
the immediate need of podiatric referral. The assessment tool is an excellent guide to
support practitioners in the evaluation of high risk patients such as diabetics suffering
from peripheral neuropathy. In today’s realm of healthcare, providers depend on various
sources and experts to improve patient care through collaboration (Barry, 2015).
Up until the mid-1990s, Charcot foot was thought of as a rare sensory deficit
condition but experts later recognized it as a destructive process that led to
immobilization to prevent further injury or trauma by imposing non weight-bearing until
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the acute phase had been resolved (Veillette, 2016, p.99). Success of treatment is based
on increasing awareness in practitioners who routinely provide care for the diabetic
patient population.
One particular study conducted by Botek et al. (2010) referred to a 53 year-old
male who was misdiagnosed in the emergency department after presenting with multiple
symptoms including pain, redness, and edema to the foot and ankle. This patient was kept
in the hospital and received a course of IV antibiotics, then discharged home with oral
antibiotics and instructed to follow up with his primary care physician. After being seen
by the primary care physician (PCP) two to three additional times, the patient was
eventually referred to an orthopedic specialist and diagnosed accurately with Charcot
foot, but the damage suffered to the foot and ankle was irreversible at that point.
Estimations are that 0.1 to 5% of all diabetics will acquire Charcot foot at some
point during their disease with an increase in odds for those suffering from end-stage
neuropathy. Furthermore, those patients having foot sores or ulcerations are more prone
to require limb amputation; therefore, “it is extremely important for the foot and ankle
specialist to judiciously approach the Charcot joint” (Bernstein, Ritter & Diamond, 2012,
pg. 2).
Another study consisted of two groups of patients. Group 1 was comprised of
eleven patients diagnosed within one month of onset of Charcot symptoms while Group 2
consisted of thirteen patients, all being diagnosed within three months of onset. Both
groups were treated immediately upon diagnosis with non-weight-bearing measures;
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however, the study found those in Group 1 were only immobilized for a time period of 3
months as opposed to those in Group 2 who had to remain immobilized for a total of 5
months. The delay in diagnosis and treatment had a substantial impact on the patients’
outcomes. All participants in Group 2 advanced to fracture of the foot and resulted in
rocker bottom foot deformities (Schade & Anderson, 2015). The ultimate goal of acute
Charcot of the foot and ankle is early detection and stabilization to minimize the risks of
infection, ulcerations, calluses, and amputation.
According to O’Rourke (2010), a total of 3,445 patients who had either an above
or below the knee amputation were included in a study over a period of nine years. Over
60% of the patients had peripheral neuropathy from diabetes, trauma, or other
complication of Charcot foot. The study showed that healthcare professionals, including
nurse practitioners, were among those who did not recognize potential issues, which
delayed care and led to amputations.
As a result of impaired peripheral sensory neuropathy in patients suffering from
type 2 diabetes, patients may have no specific recollection of injury. The initial indicator
of Charcot foot may include an abrupt alteration in the appearance of the foot or ankle
and or discoloration (Sanders, 2014). Therefore, patients often delay seeking medical
treatment due to vague symptoms or being unaware they have sustained any type of
injury.
The current literature supports the need for further education and assessment tools
to aid in the correct diagnosis and treatment referrals for patients who are at higher
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probability of Charcot foot. It is imperative that practitioners be given every means of
identifying these patients and intervening before life threatening complications occur.
Currently, there are various advanced assessment tools available, but they are directed
toward the advanced specialist skills. This project assessment tool will serve as a user
friendly assessment tool for nurse practitioners to assist in the early detection and
prevention of complications such as Charcot foot and as a guide in the next step of
treatment options.
Implications for Practice
Due to the rarity and often overlooked complication of peripheral neuropathy
known as Charcot foot, diagnosis and treatment poses a critical issue for healthcare
practitioners, including nurse practitioners (Rogers et al, 2011). Therefore, an assessment
tool is needed to serve as a guide for nurse practitioners to assist in the early recognition
and treatment and to prevent further complications and possible loss of limb.
Nurses have a vital responsibility in helping to prevent foot ulcers and
amputations through means such as education, screening high-risk populations, and
assessment and intervention. Foot care education is crucial for all diabetic patients but
more so those at an increased risk due to neuropathy. Nurses can encourage and teach
patients how to perform daily foot exams as well as consequences of untreated wounds or
delay in care. According to the WHO, diabetes is becoming an epidemic in most
countries; therefore, evidence demonstrates that the burden of helping to avoid to
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significant consequences lie on both healthcare providers as well as communities as a
whole (Aalaa, Malazy, Sanjari, Peimani, & Moharjeri-Tehrani, 2012).
Diabetic foot complications are foremost contributors to greater morbidity and
mortality rates. Without obvious signs of inflammation such as warmth, erythema, or
function deficit, it is a significant challenge for healthcare providers to diagnose Charcot
foot. “Foot complications in people with diabetes can be difficult to treat and
conventional therapies often fail, leading to amputations; thus, prevention of this
condition is of paramount importance” (Houghton, Bower & Chant, 2013, p. 1).
Advanced practice nurses must be willing to accept continuous new evidence and tools
that will improve patient outcomes as an integral part of their practice. Patients rely on
the knowledge and skill of healthcare professionals to ensure their well-being and
positive outcomes. Assessment is a key element of the nursing role for all patient
populations but more so for those individuals suffering from major diseases such as
diabetes or other causes of peripheral neuropathy. The American Diabetes Association
reports that 60–70% of people with diabetes are affected with peripheral nerve damage,
which can advance to Charcot foot, and approximately 0.5% of these patients will
progress to Charcot. This data is especially relevant to nursing practice and advanced
assessment skills.
Implications for Social Change
Diabetic neuropathy is considered the most frequent complication of type 2
diabetes mellitus and affects generally 50% of all diabetic patients. As stated by the
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American Diabetes Association [ADA] (2013), type 2 diabetes has the potential for
severe systemic complications, such as peripheral neuropathy, which is likely to lead to
devastating injuries. Due to the loss of sensation, patients are often unaware of wounds or
other abnormalities and therefore; delay seeking treatment. Due to the rarity of Charcot
foot, healthcare providers often dismiss or overlook this serious complication and initiate
other forms of treatment. According to Fowler (2007), “current statistics indicates
diabetes will continue to affect the United States population for the foreseeable future and
is by no means limited to the United States” (p. 42). Additionally, the complications
associated with this disease will also continue to be prevalent among those affected and it
is the responsibility of providers to seek resources to assist them with accurate and
appropriate diagnoses and treatment options.
As with many other chronic health conditions, the social and mental aspects of
type 2 diabetes can be devastating for patients, families, and care givers alike. Diabetic
treatment regimens must be maintained on a daily basis, despite social pressures,
economic status, or distracting life events (Welch, Jacobson & Weinger, 2008). While
type 2 diabetes typically develops or manifests in middle adulthood, this may
significantly influence motivation to seek treatment and may require greater efforts or
willingness to change. Even in the early phase, subtle complications such as foot calluses
may appear to be minor and unimportant for the diabetic patient, thus delay in seeking
treatment.
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Other facets to consider are the costs of medical management, wound care,
potential vascular interventions, infection control, wound closure, off-loading, and
alternative and adjunctive therapies. The primary preventative goal is tight glycemic
control and includes patient monitoring of blood glucose levels in addition to periodic
hemoglobin A1C levels. The cost of diabetic testing supplies can be overwhelming for
many people who do not have access to healthcare coverage. In addition, once an
ulceration or infection has occurred, management of these wounds can be difficult to treat
and may require numerous and lengthy treatment options. Furthermore, once aggressive
therapy has been initiated, weight bearing is often limited or may necessitate complete
offloading of the foot.
Socioeconomic issues begin with extensive healing. For patients who are unaware
of an injury, which progresses to an ulceration, “the average cost of treatment ranges
from $3609 to $27, 721” (Sumpio, 2012, p. 13). Regardless of whether a patient is in
need of complex therapy over an extended period of time or is simply required to be in
some form of offloading device during the acute phase of Charcot foot, the potential for
financial strain is inevitable. Complications of diabetic foot conditions are typically
debilitating to patients, families, and caregivers alike. Patients are often times unable to
continue working and have to rely on others or governmental assistance programs to
sustain their daily lives. Others who are permanently disabled are forced to file for longterm social security disability, which is an extremely long and drawn out process that
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may or may not be approved initially. For those who gain approval, the length of time for
their first payment is typically six to seven months.
As stated previously, early detection is vital in advancement to further injury and
reduce the incidence of long-term or permanent disability. The development of an
assessment and screening tool specific to the diabetic foot is one method of ensuring
early detection and intervention, following ADA recommended guidelines for treating
Charcot foot.
Project Strengths, Limitations, and Recommendations
The strengths of the assessment tool include the outlined specific areas of the foot
to be assessed and inclusion of any identified abnormalities. Also, a section exists for
pertinent patient data to be considered such as latest HgA1C levels, which indicate
controlled or uncontrolled blood glucose levels over a three month period. This data is
especially important since this directly relates to progression of healing. Additionally, the
tool contains instruction for further treatment or referral based on the assessment
findings.
Limitations of the project involved an initial negate by one practitioner to accept
the terminology of Charcot foot but rather felt it was simply a complication of diabetes
and felt it could be treated as such. After further education and the development of the
assessment tool, which was presented at the annual nurse practitioner symposium, the
project and tool were more widely accepted. Additionally, various other advanced
practice nurses have since voiced an interest in gaining information on how to perform a
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more structured foot and ankle examination on their diabetic patient population. The
interest has been from practitioners within local acute care settings as well as community
clinics.
Recommendations for the project were made by members of the area nurse
practitioners and consisted of the addition of BMI (body mass index) and specific
interpretation of monofilament points to the assessment tool.
Analysis of Self as a Scholar
Throughout this journey, I have learned so many things about myself, not only as
a person but as a contributing academic scholar. I have grown exponentially in the areas
of professionalism, academic peer, clinical specialist, and hope that my contribution to
the diabetic patient population will have a positive effect on patient outcomes. Although
this was a long and sometimes tiring feat, I have remained steadfast on my path to a
doctoral degree. As an educator, I have also learned to be more detail oriented and know
that whatever experience and knowledge I can offer will hopefully have a lasting
impression on the careers of my students. They rely on me to be knowledgeable on the
content I present to them in order for them to be successful . Remaining current on
evidence based practices and having a desire for knowledge will have a direct impact on
patients whether it be at the bedside or through experiences shared with students or
novice nurses. Lastly, I have gained confidence in myself as a nurse and scholar and will
be eternally grateful to my mentors, peers, fellow students, and professors for seeing me
through this process.
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Analysis of Self as a Practitioner
Confidence is a word that comes to mind when I think about myself as a
practitioner. When I began as a novice nurse over twenty years ago that was a descriptor I
never believed would be a part of who I was as a nurse. I was withdrawn, timid, and
fearful of making mistakes. Although I had received the same education as my peers, I
was lacking confidence as a practitioner. However, as time went on and I was forced to
step up and advocate for my patients, I could visibly see a difference in myself. I knew I
had to be the voice for those who could not speak for themselves. Despite this newly
gained confidence, I was unaware of what was missing. The years of experience of
practicing in the emergency department had exposed me to a vast array of situations that
would expand my knowledge of diseases, trauma related injuries, skills, and treatments,
but little did I know it I was not practicing holistic nursing.
Without the DNP program at Walden University, I believe I was confident and
even competent in the skills and tasks I was performing, but did not realize there was so
much more I needed to learn until I reached this point in my career. The DNP path has
given me a new feeling of confidence in myself as a person and a practitioner.
Assessment was always a skill I felt I possessed but throughout the scholarly progression,
I came to realize there was so much more to learn. The entirety of my career had been
based on the premise of short term interventions that would provide a temporary stability
until definitive treatment could be attained elsewhere. I value the time I spent in the
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emergency department all these years but my view of what patient care really was had
been distorted.
My goal after attaining an advanced education is to deliver the utmost quality of
care to my patients and improve overall quality of life through prevention, anticipating
patient needs, and integrating advanced practices into patient care.
Analysis of Self as Project Developer
An integral part of the project was the use of literature review as a means of
incorporating evidence based practices into patient care through the development of an
assessment tool for use by nurse practitioners to assist in the early identification of
Charcot foot. In collaboration with my mentor, I recognized a need for further education
and design of a tool that would is easy to follow and would adhere to ADA
recommendations. In addition, I utilized content experts such as diabetic educators,
podiatry, and a nursing informatics specialist to assist with the project. As an integral part
of the process, I have taken into consideration the vast amount of recommendations and
assessment techniques from various podiatric specialists who are experts in their fields
and have treated patients with Charcot foot. Once I had gained a sense of the current need
and gained knowledge on this topic, I was able to develop the tool and present it to areas
nurse practitioners for further input.
Throughout the development process, a majority of the inspiration came from
personal experience with my husband who suffers from Charcot foot due to the effects of
type 2 diabetes and peripheral neuropathy. The delay in diagnosis was in part due to the
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severity of sensory deficit in his feet but also due to the lack of knowledge on the part of
the practitioner who was treating him for a simple nondisplaced foot fracture. After
several long months of seeing no improvement and the edema continuing, the inevitable
happened and he incurred full blown Charcot foot. I as a practicing member of the
healthcare team, had not been exposed to this condition before and was not something I
learned throughout my nursing education; therefore, I was unaware of the severity of his
condition until we sought treatment from a podiatrist specializing in diabetic foot
conditions. The delay in diagnosis had resulted in permanent deformity of his foot and he
underwent and extended acute phase in which he was placed in a correct offloading boot
until the remodeling phase was completed. The physical and mental trauma he had
endured was just beginning and would carry forward with him as an everlasting reminder.
I found myself being left with feelings of inadequacy as a practitioner and felt as though I
should have recognized the manifestations and intervened sooner. This turn of events is
what inspired me to dedicate the DNP project to early detection and prevention for other
diabetic patients.
Despite the amount of time this project entailed, the reward was the overall end
project, which was an assessment and screening tool that would be utilized in the care of
diabetic patients and could potentially save at least one person from suffering from the
devastating effects of Charcot foot. I have learned that with persistence and dedication, I
can make a contribution to the outcome of patients in the future and also that I have the
ability to make a difference. One of the single most important aspects of this project was
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the continued support from my professors and my mentor who provided me with valuable
feedback and encouragement.
Analysis of Self as a Professional
Of all my years in nursing, I feel more of a professional and contributor than ever
before. Despite the various roles and titles throughout my career, my role as an educator
and scholar is the most important. I have a long road ahead of me regarding contribution
to the academic world, but I know the end result will be a sense of gratification in
knowing I had an impact on someone’s life and will be respected in my field. In spite of
the fact that I have not yet reached completion, I have already gained a new respect from
my peers and students. Regardless of what the future holds, I can honestly say I have
made a difference. I am able to see proof of this through the eyes of students who have
that aha moment when things start to come together or during graduation when I can see
the growth and maturity from the day they entered the nursing program to being
confident and ready to practice independently. My confidence has reached a new high
and I look ahead to what the future holds. I plan to continue with expanding my
professional horizons by publishing in various medical and nursing journals with the
hope of having a positive effect in the nursing profession.
Summary
Charcot foot is a devastating and potential life threatening complication of
diabetes and those suffering from peripheral neuropathy. As stated previously, many
patients suffering from peripheral neuropathy or impaired sensory perception may
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experience injuries that are unaware until they begin to see visible signs of trauma such
as edema, discoloration, or deformity. For these reasons, patients often times delay
seeking treatment or are treated by healthcare providers with little or no knowledge on
the clinical manifestations of diabetic foot complications.
If left untreated, Charcot foot may progress to permanent disfigurement or
amputations. Early detection and intervention is the key to preventing this serious
condition. The development of an assessment screening tool and following ADA
recommendations will assist nurse practitioners and benefit the diabetic population.
Currently, there are multiple assessment tools available to specialists in this area such as
orthopedics and podiatry but are far more advanced than what is needed for early
recognition and referral for advanced practice nurses. After receiving feedback regarding
a need from local advanced practice nurses, I created an assessment and screening tool,
along with screening algorithm, and assessment and treatment practice guidelines, as a
means to assist them in the care of the diabetic patient population who are at risk due to
peripheral sensory deficits. In doing so, the goal is for immediate intervention, treatment,
and referral to podiatry specialty if warranted and prevent further damage or injury.
Also, a lack of education regarding the rarity and complexity of Charcot foot was
identified and therefore; the information was presented to area nurse practitioners at an
annual conference, which is discussed further in the following section.
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Section 5: Scholarly Project
Introduction
The DNP project is intended to improve patient care with the use of an assessment
and screening tool and algorithm to aid in early identification of Charcot foot in the type
2 diabetic patient populations. The project involves the identification of a practice
problem and the completion of a project that will lay ground work for future scholarship.
According to the American Association of College of Nurses (AACN) (2006), “doctoral
education in nursing is designed to prepare nurses for the highest level of leadership in
practice and scientific inquiry. The DNP is a degree designed specifically to prepare
individuals for specialized nursing practice, and The Essentials of Doctoral Education for
Advanced Nursing Practice articulates the competencies for all nurses practicing at this
level” (p. 7) Assessment is a key element in nursing practice and this project addressed a
need involving early identification of Charcot foot and referral for type 2 diabetic patients
suffering from peripheral neuropathy.
Problem Statement
Diabetic neuropathy is the most prevalent complication of type 2 diabetes mellitus
and affects equal to 50% of all type 2 diabetics. Peripheral neuropathy, or peripheral
nerve damage, causes significant issues such as nonhealing wounds, major infections,
amputations, and Charcot neuropathic osteoarthropathy (CN), commonly referred to as
Charcot foot, which involves the soft tissue and bones of the foot and ankle and thus
leads to permanent deformities. This may transpire if the bones in the feet suffer fractures
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and the foot becomes misaligned. Although experiencing a fracture would be extremely
painful to most people, this particular condition can be painless to the diabetic patient
since nerves were damaged from diabetes prior to the fracture. The foot or feet may
subsequently lose muscle support, eventually converting to deformity. Diagnosis can
sometimes be difficult due to the potential of mimicking other conditions like cellulitis or
deep venous thrombosis, and because diagnosis of a Charcot fracture cannot be made
definitively until bone changes occur. Therefore, the focused problem in the project was
inconsistency of healthcare providers in the recognition and referral of patients with
potential Charcot foot.
Purpose Statement
According to Lin and Lorenzo (2013), “in type 1 DM, distal polyneuropathy
typically becomes symptomatic after many years of chronic prolonged hyperglycemia,
whereas in type 2, it may be apparent after only a few years of known poor glycemic
control or even at diagnosis” (para. 2) Symptoms affect sensory, motor, and autonomic
systems of the body. When neuropathy progresses to Charcot foot, it becomes a serious,
potential limb-threatening complication and during the acute phase, is considered to be an
inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment poses
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al,
2011). For this reason, the intent of the project was the development of an assessment
and screening tool, with integration of ADA recommendations, for nurse practitioners to
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promote early detection and treatment of Charcot foot so as to avoid additional injury and
possible loss of lower limb or foot.
Goals and Outcomes
The purpose of this project was to develop an assessment and screening tool and
integrate recommendations set forth by the American Diabetes Association in an effort to
assist nurse practitioners in the assessment, diagnosis, and treatment of Charcot foot in
the diabetic patient with peripheral neuropathy. In doing so, the goal was to improve
consistency of healthcare providers in the detection and treatment of patients with or at
risk of Charcot foot.
This section outlines the process by which an assessment tool was developed,
along with implementation and evaluation. No data was collected nor were participants
involved as the project involved the development of an assessment tool to further assist
NPs in the early detection, identification, and treatment of type 2 diabetic patients at risk
of Charcot foot.
The outcomes that were used to determine goal attainment for the project included
an evaluation planning step at the end of this DNP Project. The following outcomes were
suggested as possible starting points for evaluation planning:
Outcome 1: Healthcare providers will identify, assess, and treat patients with
Charcot foot.
Outcome 2: Healthcare providers will refer patients with Charcot foot to
appropriate specialty for follow up care.
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The detection of patient risks by nurses, which is “the ability of nurses to
accurately identify signals can lead to early interventions so that harm to patients is
minimized or circumvented” (Despins, Scott-Cawiezell & Rouder, 2010, p. 465). Nurses
and nurse practitioners are at the forefront of patient assessment, which is the first
opportunity for detection and intervention of potentially life-threatening illness and
injuries. They have a responsibility to patients to be skilled in their assessment abilities
and intervene when necessary. Charcot foot, although complex and often difficult to
diagnose, is a major complication of diabetes that requires immediate treatment after a
detailed and skilled assessment by competent healthcare professionals.
The project design was a qualitative approach, which provided an opportunity for
nurse practitioners to share their experiences and challenges when assessing the adult
diabetic patient population. “Qualitative methods offer the opportunity to obtain an indepth understanding of patient experiences and may elicit a deeper understanding of
patient’s perceptions and behaviors and the meanings they attach to their experiences”
(LaVela & Gallan, 2014, p. 32).
Background
The American Diabetes Association reports that 60–70% of people with diabetes
suffer from peripheral nerve damage, which can progress to Charcot foot and an
estimated 0.5% of these patients will actually advance to Charcot. In the majority of
cases, onset occurs following the age of 50 and after having been diagnosed with diabetes
for 15 to 20 years (Peng & Swierzerswki, 2011).
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Despite the fact that uncontrolled diabetes and loss of proprioception is the main
contributing factor leading to Charcot, researchers now believe other predisposing
elements may increase the risk such as widespread atherosclerosis, inflammation caused
by minor injury, infection, ulceration, or any other disorder in which blood flow is
impeded (Kaynak, Birsel, Guven & Ogut, 2013). Discovering the underlying etiology is a
crucial aspect in successful treatment. The incidence and prevalence of Charcot is not
known exactly but is estimated to affect 0.8-8% of the diabetic population. This number
increases to 10% when radiographic studies are used in diabetics with neuropathy. In
addition, studies have shown men and women are equally affected and typically in their
5th and 6th decades of life and having had diabetes for at least 10 years or more (Gouveri
& Papanas, 2011).
Charcot is a devastating complication of diabetic peripheral neuropathy that may
affect a person’s physical appearance and their ability to work and has the potential of
having an effect on their mental capabilities as well. Patients are often left with feelings
of depression, guilt from financial strains, and isolation. In addition, patients suffering
from Charcot experience a high rate of depression and anxiety due to physical mobility
restraints and chronic pain. Male patients are at an even greater threat of these
complications as a resulting from an inability to work and provide for their families
financially (Chapman, Shuttleworth & Huber, 2014).
Finally, studies show that mortality rates of individuals with Charcot arthropathy
are significantly higher than those who have simple diabetic foot ulcerations as well as
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those with type 2 diabetes lacking foot complications at all. The comparable rates are
28.3, 37.0, and 18.8% (Sohn, Lee, Stuck, Frykberg & Budiman-Mak, 2009).
Significance for Future Practice, Research and Social Change
The American Diabetes Association has developed recommendations for all
healthcare practitioners to follow regarding the diagnosis, treatment, and surgical
intervention of Charcot foot with the goal of rapid identification of signs and symptoms
and appropriate treatment regimens as a means of preventing further complications. The
guidelines address the areas of diagnostics, medical therapy, and surgical treatment of
active Charcot neuropathy and stress the importance of early recognition and offloading
and prevention of recurrence or new episodes of CN or other diabetic foot complications.
(Rogers et al, 2011).
Accurate assessment of the diabetic foot is a complex process requiring skill,
experience, and knowledge of not only the disease but also signs and symptoms of
potential complications. The loss of sensation due to peripheral nerve damage makes it
difficult for providers to diagnose issues as well as unseen internal problematic issues
such as destruction of bone tissue and cartilage as a result of uncontrolled hyperglycemia.
It is critical that diabetic patients are adequately censored and made mindful of the
possible complications that derive from this disease. Through lessening the percentage of
amputations and enhancing quality of life by way of education and consistent monitoring,
there will be a decrease in the amount of money spent on the long-term support of the
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patient with diabetes (Meyers, 2013). However, many clinicians lack experience in the
area of Charcot foot assessment and often consider it as simply “a diabetic foot”.
According to Zgonis (2010), there is a limited amount of scientific literature in
regard to treatment protocols and guidelines for management of Charcot foot and ankle
deformities and may be in part due to the presence of each individual case of Charcot of
the foot and ankle. Whereas many patients pose with obvious deformities, there are a
higher number of those who have, little, or vague complaints, which add to the difficulty
of accurate diagnosing for the practitioner.
Due to the fact that type 2 diabetics are at risk for numerous multisystem
complications, all healthcare personnel, including nurse practitioners, have a
responsibility to patients to be knowledgeable and competent in advanced assessment
skills in hopes of preventing further complications. According to Rogers et al (2011),
“the Charcot foot in diabetes poses many clinical challenges in its diagnosis and
management. Despite the time that has passed since the first publication on pedal
osteoarthropathy in 1883, we have much to learn about the pathophysiology, and little
evidence exists on treatments of this disorder” (p. 2123). Identifying this problem in its
initial stages is critical to effective treatment. Patients should contact a podiatrist at the
earliest onset of symptoms. Occasionally, diagnosis is problematic given this condition is
capable of mimicking other major disorders such as cellulitis or deep venous thrombosis,
and especially since diagnosis of a Charcot fracture is unable to be made definitively until
bone changes occur. The initial indications of the Charcot foot are frequently mild in

57
nature, but can become abundantly more pronounced with unperceived repetitive trauma.
Charcot foot typically worsens slowly, with age; rapid progression is uncommon, and
should motivate a rapid re-evaluation. Since undiagnosed Charcot can advance
considerably to grim outcomes including infection, deformity, amputations, disability,
loss of employment, financial and mental strains, and life-long devastating effects, it is
crucial for practitioners to be knowledgeable and skilled in assessment and treatment
methods.
Implications for Practice
Due to the rarity and often overlooked complication of peripheral neuropathy
known as Charcot foot, diagnosis and treatment poses a critical issue for healthcare
practitioners including nurse practitioners (Rogers et al, 2011). Therefore, an assessment
and screening tool is needed to serve as a guide for nurse practitioners to assist in the
early recognition and treatment and to prevent further injury and possible loss of limb.
Nurses’ position in prevention of foot ulcers and amputations is imperative by means of
education, screening high-risk populations, and assessment and intervention. Foot care
education is vital for all diabetic patients but more so for those posing an increased threat
due to neuropathy. Nurses can encourage and teach patients how to perform daily foot
exams as well as consequences of untreated wounds or delay in care. According to the
World Health Organization, diabetes is becoming an epidemic in most countries;
therefore, evidence demonstrates significant consequences lie on both healthcare
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providers as well as communities as a whole (Aalaa, Malazy, Sanjari, Peimani, &
Moharjeri-Tehrani, 2012).
Diabetic foot complications are key contributors to soaring morbidity and
mortality rates. Without obvious signs of inflammation such as warmth, erythema, or
function deficit, it is a demanding challenge for healthcare providers to diagnose Charcot
foot. “Foot complications in people with diabetes can be difficult to treat and
conventional therapies often fail, leading to amputations; thus, prevention of this
condition is of paramount importance” (Houghton, Bower & Chant, 2013, p. 1).
Advanced practice nurses must be willing to accept continuous new evidence and tools
that will improve patient outcomes as an integral part of their practice. Patients rely on
the knowledge and skill of healthcare professionals to ensure their well-being and
positive outcomes. Assessment is a key element of the nursing role for all patient
populations but more so for those individuals suffering from major diseases such as
diabetes or other causes of peripheral neuropathy. According to the American Diabetes
Association, 60–70% of people with diabetes acquire peripheral nerve impairment that
can expand to Charcot foot and roughly 0.5% of these patients progress to Charcot. This
data is especially relevant to nursing practice and advanced assessment skills.
Implications for Social Change
Diabetic neuropathy has the utmost widespread effect of type 2 diabetes with up
to 50% of all diabetic patients affected. As per the American Diabetes Association
[ADA] (2013), type 2 diabetes involves uncompromising systemic consequences, such as
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peripheral neuropathy, which has the potential of leading to devastating injuries. Due to
the loss of sensation, patients are often unaware of wounds or other abnormalities and
therefore; delay seeking treatment. Additionally, due to the rarity of Charcot foot,
healthcare providers often dismiss or overlook this serious complication and initiate other
forms of treatment. According to Fowler (2007), “current statistics indicates diabetes will
continue to affect the United States population for the foreseeable future and is by no
means limited to the United States” (p. 42) The complications associated with this disease
will also continue to be prevalent among those affected and it is the responsibility of
providers to seek resources to assist them with accurate and appropriate diagnoses and
treatment options.
As with many other chronic health conditions, the social and mental aspects of
type 2 diabetes can be devastating for patients, families, and care givers alike. Diabetic
treatment regimens must be maintained on a daily basis, despite social pressures,
economic status, or distracting life events (Welch, Jacobson & Weinger, 2008). While
type 2 diabetes typically develops or manifests in middle adulthood, this may
significantly influence motivation to seek treatment and may require greater efforts or
willingness to change. Even in the early phase, subtle complications such as foot calluses
may appear to be minor and unimportant for the diabetic patient, thus delay in seeking
treatment. Other facets to consider are the costs of medical management of wound care,
potential vascular interventions, infection control, wound closure, off-loading, and
alternative and adjunctive therapies.
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Socioeconomic issues begin with extensive healing. For patients who are unaware
of an injury, which progresses to an ulceration, “the average cost of treatment ranges
from $3609 to $27, 721” (Sumpio, 2012, p. 13). Regardless of whether a patient is in
need of complex therapy over an extended period of time or is simply required to be in
some form of offloading device during the acute phase of Charcot foot, the potential for
financial strain is inevitable. Complications of diabetic foot conditions are typically
debilitating to patients, families, and caregivers alike. Patients are often times unable to
continue working and have to rely on others or governmental assistance programs to
sustain their daily lives. Others who are permanently disabled are forced to file for longterm social security disability, which is an extremely long and drawn out process that
may or may not be approved initially. For those who gain approval, the length of time for
their first payment is typically six to seven months. Early detection is vital in
advancement to further injury and reduces the incidence of long-term or permanent
disability.
Definition of Terms
The principal terms used throughout this project included type 2 diabetes,
peripheral neuropathy, Charcot foot, podiatric, acute, inflammatory, deformity,
amputation, and offloading.
Type 2 diabetes is the most common form of diabetes and is defined as a
condition in which the body fails to utilize insulin properly, otherwise known as insulin
resistance. Typically, the pancreas produces an excess of insulin to accommodate but,
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over time it is adequately produce the body’s requirement of insulin to maintain blood
glucose at normal levels (ada.org, n.d.). Peripheral neuropathy refers to the destruction
or dysfunction of peripheral nerves, which are damaged by uncontrolled elevated blood
glucose levels, traumatic injuries, infections, metabolic problems and exposure to toxins
(mayoclinic.org, n.d.). Charcot-Marie-Tooth (Charcot Foot or CMT) is named for three
physicians who were first to describe it in 1886: Jean-Martin Charcot, Pierre Marie, and
Howard Henry Tooth (CMTA, 2010). It is defined as a serious and potentially lifethreatening complication associated with diabetes, which is characterized by various
degrees of bone, joint, soft tissue, foot and often ankle involvement and is derived from
underlying neuropathy, trauma, and perturbations of bone metabolism and involves
inflammation during the acute phase (Rogers et al, 2011). Podiatric refers to the specialty
of a podiatrist who is a doctor of podiatric medicine (DPM), also known as a podiatric
physician or surgeon. Podiatrists diagnose and treat conditions of the foot, ankle, and
related structures of the leg (“what is a podiatrist?” 2014). Acute is characterized by
sharpness or severity, sudden onset, short course, or requiring short-term medical care (as
for serious illness or traumatic injury) (merriam-webster.com, 2014). Inflammatory refers
to having to do with the body's response to either invading foreign substances (such as
viruses or bacteria) or to direct injury of body tissue (“inflammatory”, 2014). Deformity
is defined as the quality or state of being deformed, disfigured, or misshapen
(“deformity”, 2014). Amputation is the accidental or intentional removal of a limb or
body part (“amputation”, 2014). Offloading refers to taking the load off or transfer from
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one place to another such as reduction of pressure. Removing pressure from one area of
the foot to another; effective reduction in pressure (“offload”, 2016).
Evidence-Based Practice Model
The problem identified within the adult type 2 diabetic population, who are at risk
of Charcot foot, and the need for an assessment tool for healthcare practitioners is an
example of the Iowa model of evidence-based practice. The Iowa model begins with a
trigger or identified problem, which may also be a knowledge-based problem and
involves the development of a team of stakeholders and a practice change is developed,
implemented, and evaluated (Malone & Bucknall, 2013, 139).
The Iowa Model for evidence-based practice includes knowledge and problem
triggers, which prompt providers to evaluate current practices as well as promoting
research when evidence is lacking (Rempher, 2006). “The Iowa Model of Research in
Practice infuses research into practice to improve the quality of care, and is an outgrowth
of the Quality Assurance Model Using Research (QAMUR). Research utilization is seen
as an organizational process. Planned change principles are used to integrate research and
practice. The model integrates evidence-based healthcare acknowledges and uses a
multidisciplinary team approach” (“Evidence-based Practice”, 2014).
According to a study by Varaei, Salsali & Heshmat (2013), the Iowa Model was
followed in a before and after design and included 19 baccalaureate nurses working on an
endocrinology unit in which the primary patient population consisted of diabetics with
chronic leg ulcers. The focus of the study was whether evidence based practice training
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courses could improve nursing skills. Results indicated trained nurses can prevent
significant complications in diabetic patients including amputations and other adverse
effects by means of early recognition and treatment interventions.
This model has served as a reference for the project since the primary goal is
directed at improving patient health and outcomes by identifying a trigger such as
misdiagnosed Charcot foot, then integrating a multidisciplinary team to design an
improvement plan such as assessment tool development and review of ADA policy and
practice guidelines. “In this model, knowledge- and problem-focused triggers lead staff
members to question current nursing practice and whether patient care can be improved
through the use of research findings” (Titler & Moore, 2010, p. S3). Putting evidence into
practice can be a complex process but necessary for improvements in healthcare and
patient outcomes. The IOWA Model has been a valuable resource in the project by
providing a systematic process to identify and address an issue in diabetic health.
Theory
Change is brought about in healthcare through various driving forces. The concept
of identifying a problem and using evidence-based practice to implement change is an
example of following the nursing process, which is a systematic approach to patient care
with the goal of improving patient care. Lippitt’s theory of change is a model of nursing
that mirrors the nursing process and follows the same four process elements including
assessment, planning, implementation, and evaluation (Mitchell, 2013). The project has
identified the problem of assessing the diabetic patient at risk of Charcot foot as a
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problematic area for nurse practitioners due to its complexity and challenges in diagnosis.
The plan was to develop an assessment and screening tool to aid in early detection in
those patients at risk or who display clinical manifestations correlating to Charcot foot.
The planning stage is designed to utilize the screening algorithm to determine the correct
treatment or referral action for the patient and followed up at an appropriate time, which
is the final evaluation stage.
Literature Search Strategy
The search for literature was conducted electronically and used the following
databases: CINAHL, Medline, PubMed, EBSCO, and Walden University Library.
Articles older than 10 years were not considered and the terms used for the search were:
diabetes, type 2 diabetes, diabetes statistics, neuropathy, peripheral neuropathy, diabetic
complications, Charcot, Charcot foot, Charcot-Marie-Tooth, podiatry, podiatric,
orthopedic complications, foot deformities, diabetic assessment forms, foot assessment,
offloading, and peripheral neuropathy assessment.
Literature Review
“Charcot neuroarthropathy is an often overlooked complication in diabetic
patients with peripheral neuropathy. A group of experts reported that 25% of patients
referred to their facility who had Charcot neuroarthropathy had not received a correct
diagnosis at the referring institution. The incorrect diagnoses included infection, gout,
arthritis, fracture, venous insufficiency, and tumor” (Botek, Anderson & Taylor, 2010, p.
596). This article focused in detail on the devastating effects of misdiagnosed Charcot
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and emphasized the importance of accurate assessment by healthcare providers. The
authors also discussed a case in which a 53 year-old male presented to the emergency
department with a 3 day history of pain, redness, and swelling to the foot and ankle and
was misdiagnosed with cellulitis, admitted to the hospital for a course of antibiotics,
discharged home with oral antibiotics, seen at his primary healthcare providers office 2-3
more times for follow up, then finally referred to an orthopedic specialist where they
were accurately diagnosed with Charcot foot in the acute phase. By this time, there was
irreversible extensive damage to the foot.
According to O’Rourke (2010), from 1999-2008 of patients who underwent either
a below or above the knee amputation, 60% suffered from diabetic neuropathy and had
some type of trauma, nonhealing wound or other complication such as Charcot foot.
Based on an exhaustive review and analysis of the study, the primary issue for patients at
a heightened chance of foot and ankle problems was the identification and referral to the
appropriate specialist (O’Rourke, 2010). Healthcare professionals, including nurse
practitioners, were among those who did not recognize potential issues, which delayed
care and led to amputations of the 3,445 patients included in the study.
Symptoms of Charcot foot affect sensory, motor, and autonomic systems of the
body. When neuropathy progresses to Charcot arthropathy, it becomes a serious, potential
limb-threatening complication and during the acute phase, is considered to be an
inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment poses
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al,

66
2011). Therefore, an assessment and screening tool for nurse practitioners is needed to
assist in the early recognition and treatment of Charcot foot to prevent further
complications and possible loss of foot or lower extremity.
Mumoli & Camaiti (2012) discussed a case of Charcot in the Canadian Journal of
Medicine in which a 59 year-old male reported complaints of a plantar ulcer for two
months but after examination, his healthcare provider discovered that his foot was also
deformed; however, the patient had such severe neuropathy that he felt no pain at all.
They go on to state early detection is essential and “prevention of disease progression
remains the mainstay of treatment, including prompt immobilization, absolute non–
weight bearing and professional foot care on a regular basis” (p. 1392). While even the
slightest of infection, injury, or minor surgery may trigger the body’s inflammatory
response, without the protective barrier of pain being present, diabetic patients with
sensory impairment are at greater risk of further injury and early recognition is crucial
(Kaynak et al, 2013).
Another valid argument derives from a literature review by Milne, Rogers,
Kinnear, Martin, Lazzarini, Quinton & Boyle (2013), which discussed suggestions to
assist healthcare providers in making early diagnoses of Charcot foot, choosing the
appropriate treatment regimen and reducing the incidence of further complications
including amputations, sepsis and death. “Charcot neuroarthropathy (CN) continues to be
a persistent challenge for clinicians, especially in its acute phase. The report indicated
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that the diagnosis of CN is missed in as many as 79% of cases and an accurate diagnosis
can be delayed up to 29 weeks” (p. 9).
According to Gouveri & Papanas (2013), accurate diagnosis of Charcot can often
be challenging. The authors stress the significance of patient and physician awareness in
order to gain prompt diagnosis and lessen the burden of foot complications. “Charcot
arthroneuropathy is a potentially limb-threatening condition which, beyond the emotional
and social burden of physical dysfunction, has been associated with increased mortality”
(Gouveri & Papanas, 2013, p. 59). In addition, the article contains six practical point
recommendations for clinicians to aid them in early detection and management and
include: Charcot should be considered in every diabetic patient with neuropathy;
irrespective of whether the diagnosis is only suspected, immediate offloading should be
initiated; if plain x-rays are negative, this should not deter offoading; education to
patients and physicians to increase early detection will be beneficial; ulceration or
infection in the plantar aspect of the foot should be avoided and; surgical intervention
may be required (consult a podiatric specialist). A detailed foot assessment and
documentation utilizing a specified assessment tool, which follows ADA guidelines by a
skilled practitioner, is recommended for all diabetic patients.
Finally, according to Jackson (2011), many diabetic patients with existing
neuropathy may present with other distracting issues such as foot ulcerations, swollen
extremities, or have no complaints of pain or discomfort at all; clinicians still have the
responsibility to perform a thorough examination of the diabetic foot and must be skilled

68
in their assessment techniques. Most complications of Charcot can be avoided with
immediate treatment in the acute phase. While it is equally important to exclude other
infectious processes or conditions such as DVT, “the overriding goal of treatment is to
avoid amputation and prevent further deformity. Good outcomes can be managed with
footwear that allows adequate gait and activity, thus sustaining overall quality of life”
(Jackson, 2011, para. 2).
Methods Approach: Introduction
The purpose of this quality improvement project was to develop an assessment
and screening tool and integrate ADA recommendations to assist healthcare providers in
the early detection of Charcot foot for the diabetic population. The target population for
this project was the adult diabetic population who have been diagnosed as having type 2
diabetes for at least ten years, being treated with either oral hypoglycemic or insulin
therapy, and those either having or at risk of peripheral neuropathy. Inclusion also
involved those patients with a history of or currently being treated for any type of foot
ulceration, wound, and injury, complaints of foot or ankle pain, and patients who have a
documented change of foot appearance. Stakeholders for this project were the patients,
private insurance carriers, Medicare and Medicaid, podiatrists, and healthcare
practitioners who provide care to diabetic patients. This section will outline how the
project achieved these development activities.
The steps in the course of this project were as follows:
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7. Assemble an interdisciplinary project team community of stakeholders to
guide the project
8. Review of best practices of diabetic foot assessment as presented in
evidence-based literature.
9. Integrate ADA policies and practice guidelines for the assessment,
treatment, and referral of the diabetic patient with, or at risk for
developing, Charcot foot in conjunction with the project team.
10. Develop an assessment tool of the diabetic foot in conjunction with the
project team
11. Develop an implementation plan in collaboration with the project team
12. Develop an evaluation plan in collaboration with the project team
Interdisciplinary Project Team
The multidisciplinary team members, consisting of five members, who were
invited to participate in the project based on their knowledge and expertise in the area of
diabetes and management of complications. Disciplines included diabetes education,
nurse practitioner, podiatry, IT computer personnel, and nursing informatics. Members
were selected for their knowledge and experience in treating diabetic patients, medical
specialty in podiatric medicine, computer technology, and informatics. Each member
reviewed ADA treatment recommendations regarding early detection and intervention of
patients at risk of Charcot foot as well as appropriate treatment regimens. Utilization of
valid resources such as medical specialists and those having experience in one particular
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area is beneficial for ensuring all essential elements are included in the plan design.
According to Nancarrow et al., (2013), interdisciplinary teamwork is “a dynamic process
involving two or more health professionals with complementary backgrounds and skills,
sharing common health goals and exercising concerted physical and mental effort in
assessing, planning, or evaluating patient care” (p. 2)
Team Literature Review
The interdisciplinary team members each received a copy of the goals and
objectives for the project prior to development of an assessment tool and were led
through the review of scholarly literature. Furthermore, a Gannt chart was dispersed to
each member to illustrate the incidence of Charcot foot along with information from the
American Diabetes Association and the American Podiatric Medical Association. All of
the above was provided during an initial meeting with the interdisciplinary project team.
Products
Throughout the development of this project, I collaborated with a diverse group of
experts who embodied the interdisciplinary team. The team members continuously
provided input on the needs of the nurse practitioner stakeholders as well as feedback on
the assessment and screening tool. The project was accepted and adopted by various NP
clinicians in the geographical area who were willing to integrate it into their examination
and treatment of adult type 2 diabetic patients. Furthermore, for those NPs who were
utilizing electronic medical record systems, the project tools were incorporated as part of
the patient assessment process for each visit.
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Appendix A.
Appendix A. is an example of the computation of a Scale Content Validation
Instrument (S-CVI) for a 10-Item scale with two expert raters, which was used by two
expert raters for ranking and validation of this project.
Appendix B.
Appendix B. is the Charcot Foot Assessment and Screening Tool to be used by
nurse practitioners in the adult type 2 diabetic patient population who are at risk due to
neurosensory deficits or other identified risk factors. The assessment and screening tool is
based on the American Diabetes Associations’ (2011) recommendations, which could be
utilized in the clinical setting and integrated into the patient’s electronic medical record.
Focus points on the assessment were derived from key features of the foot, which
included monofilament points, evidence of outward physical abnormalities, and severity
of peripheral neuropathy. Patients who cannot reliably detect application of the 5.07, 10-g
monofilament to designated sites on the plantar surface of their feet are considered to
have lost protective sensation” (Morgan, 2013, para. 2). The assessment and screening
tool also includes a recommendation for annual follow up or podiatric referral based on
findings of the examination by way of a screening algorithm.
Appendix C.
Appendix C. is the Charcot Foot Screening Algorithm, which provides a clear
guidance of treatment recommendations based on assessment findings. The algorithm is
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designed to guide practitioners in the care and treatment of patients based on assessment
findings.
Appendix D.
Appendix D. includes Charcot Foot Assessment and Treatment Practice
Guidelines. Due to the potential life threatening complications of type 2 diabetes and the
complexity in diagnosing Charcot foot, it is imperative that healthcare professionals, such
as nurse practitioners, be educated and competent in their assessment skills. According to
the U. S. Department of Health and Human Services Health Resources and Services
Administration Bureau of Health Professions Division of Nursing; (2002), “the adult
nurse practitioner employs evidence-based clinical practice guidelines to guide screening
activities, identifies health promotion needs, and provides anticipatory guidance and
counseling addressing environmental, lifestyle, and developmental issues” (p. 17).
Providers must maintain a level of expertise to aid in the diagnosis and treatment of all
major disease complications.
Appendix E.
Appendix E. includes the implementation and evaluation plan for the project.
Implementation is an essential component in the success of the scholarly project and
addresses the key objectives for the project and makes for a smoother transition for
completion of the project (Moran, Conrad & Burson, 2014, p. 338). Equally important is
the evaluation of the project by stakeholders to ensure the objectives are being met as
well as opportunity for revisions. The intent of both the implementation and evaluation of
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the project is to make certain that evidence-based practices are being followed (Forsyth,
Wright, Scherb & Gaspar, 2010).
Development of Products
The proposed assessment and screening tool, treatment algorithm, and treatment
and practice guidelines were developed by the project team for later implementation with
the nurse practitioner community in Northern Texas where there are currently 65
members of the Texas Panhandle Nurse Practitioners Association (TXPNPA). The
assessment tool was distributed only to practitioners who are the primary care giver of
adult type 2 diabetic patients. Part of the implementation phase included written forms of
the assessment tool as well as the computerized version for those providers who have
converted to electronic documentation. One benefit of utilizing the electronic medical
record is the assessment tool will be a mandatory inclusion for providers, which will
serve as an assessment reminder and hopefully reduce the number of undiagnosed cases.
The computerized health information system being utilized at the health clinic has the
capability of revisions to assessment templates and will be maintained by the clinic’s
computer personnel. These plans were presented to the project team for consideration and
refinement. The final DNP Project included an implementation plan developed by the
project team.
Validation of Products
Content validation in the area of Charcot foot is essential in order to go forth with
the development of treatment and practice guidelines. One method of validation is the
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computation of a Scale Content Validation Instrument (S-CVI) for a 10-Item scale with
two expert raters, which is defined as the proportion of items given a rating of quite/very
relevant by both raters involved (Polit & Beck, 2006). This particular method allows the
entire scale of items, up to 10, to be ranked by the raters as valid and relevant by the two
experts and the proportion of total items judged content valid. An example of this scale is
attached on Appendix A.
Development of Implementation and Evaluation Plan
The goal for this project is to pilot for a period of 6 months, which would allow
area nurse practitioners ample time to integrate it into their diabetic patient exam and
screening process. The project will include the assessment and screening tool, algorithm,
and treatment and practice guidelines. At the end of the allocated time period, an
electronic survey will be dispersed to practitioners via email to provide feedback on the
project tools and forms.
Project Dissemination
Dissemination of the scholarly project is an important step in the DNP project.
According to Ahmed, Andrist, Davis & Fuller (2012, p. 62), “it is our professional
responsibility to share knowledge-knowledge generated from practice.” Among the
various methods of disseminating the project, publishing in peer-reviewed journals ranks
the most prestigious. This allows the scholar to project findings to professional
colleagues rapidly. Another means is through poster presentations and at various
conferences as a podium speaker. Regardless of the chosen method of dissemination, the
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goal is to improve practice and patient safety through the process of developing a
scholarly project.
Dissemination of this project included a presentation at the annual nurse
practitioner symposium two consecutive years and initially was presented as a project
proposal. Throughout the following year, the assessment tool was developed with
assistance from my DNP mentor and members of the project team. Final dissemination
was conducted via podium presentation, as well as hand out copies of the assessment
tool, with question and answer session following. By sharing the project with an area
community network of nurse practitioners who are members of a particular region, I
contributed to the growth and development of a community organization. This option is
frequently overlooked but is an ideal collaboration to improve the overall health and
well-being of those patients it serves (Anderson, Knestrick & Barraso, 2014).
Discussion of Findings in Context of Literature
The assessment and screening tool is an excellent guide to support practitioners in
the evaluation of high risk patients such as diabetics suffering from peripheral
neuropathy. In today’s world of healthcare, providers rely on multiple sources and
experts to improve patient care through collaboration (Barry, 2015). Up until the mid1990s, Charcot foot was thought of as a rare sensory deficit condition but experts later
recognized it as a destructive process, which led to immobilization to prevent further
injury or trauma by making the patient non weight-bearing until the acute phase had been
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resolved (Veillette, 2016, p. 99). Success of treatment is based on increasing awareness in
practitioners who routinely provide care for the diabetic patient population.
One study conducted by Botek, Anderson & Taylor (2010) described a 53 yearold male who was misdiagnosed in the emergency department after presenting with
multiple symptoms including pain, redness, and edema to the foot and ankle. This patient
was admitted to the hospital and given a course of IV antibiotics, then discharged home
with oral antibiotics and instructed to follow up with his primary care physician. After
being seen by the PCP 2-3 additional times, the patient was eventually referred to an
orthopedic specialist and diagnosed accurately with Charcot foot but the damage suffered
to the foot and ankle was irreversible at that point.
It is estimated that 0.1 to 5% of all diabetics will develop Charcot foot at some
point during their disease with an increase in odds for those suffering from end-stage
neuropathy. Furthermore, those patients with foot ulcerations are more likely to require
extremity amputation; therefore, “it is extremely important for the foot and ankle
specialist to judiciously approach the Charcot joint” (Bernstein, Ritter & Diamond, 2012,
p. 2).
As a result of impaired peripheral sensory neuropathy in patients suffering from
type 2 diabetes, patients may have no specific recollection of injury. The earliest sign of
Charcot foot may include a sudden change in the appearance of the foot or ankle and or
discoloration (Sanders, 2014). Therefore, patients often delay seeking medical treatment
due to vague symptoms or being unaware they have sustained any type of injury.
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The current literature supports the need for further education and assessment tools
to aid in the correct diagnosis and treatment referrals for patients who are at high risks for
developing Charcot foot. It is imperative that practitioners be given every means of
identifying these patients and intervening before life threatening complications occur.
Currently, there are various advanced assessment tools available but are directed toward
the advanced specialist skills.
Project Strengths, Limitations, and Recommendations
The strengths of the assessment and screening tool include the outlined specific
areas of the foot to be assessed and inclusion of any identified abnormalities. Also, a
section exists for pertinent patient data to be considered such as latest HgA1C levels,
which indicate controlled or uncontrolled blood glucose levels over a three month period.
This data is especially important since this directly relates to progression of healing.
Additionally, the tool contains instruction for further treatment or referral based on the
assessment findings.
Limitations of the project involved an initial negate by one practitioner to accept
the terminology of Charcot foot but rather felt it was simply a complication of diabetes
and felt it could be treated as such. After further education and the development of the
assessment tool, which was presented at the annual nurse practitioner symposium, the
project and tool were more widely accepted. Furthermore, various other advanced
practice nurses have since voiced an interest in gaining information on how to perform a
more structured foot and ankle examination on their diabetic patient population. The
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interest has been from practitioners within local acute care settings as well as community
clinics.
Recommendations for the project were made by members of the area nurse
practitioners and consisted of the addition of BMI (body mass index) and specific
interpretation of monofilament points to the assessment tool.
Project Summary
In summary, the DNP project has the potential to impact the diabetic patient
population through a process of identifying a need and developing a project to address the
issue through evidence-based practice. Charcot foot is a devastating and potential life
threatening complication of diabetes and those suffering from peripheral neuropathy. As
stated previously, many patients suffering from peripheral neuropathy or impaired
sensory perception may experience injuries that are unaware until they begin to see
visible signs of trauma such as edema, discoloration, or deformity. For these reasons,
patients often times delay seeking treatment or are treated by healthcare providers with
little or no knowledge on the clinical manifestations of diabetic foot complications.
If left untreated, Charcot foot may progress to permanent disfigurement or
amputations. Early detection and intervention is the key to preventing this serious
condition. The development of an assessment and screening tool and following ADA
recommendations will assist nurse practitioners and benefit the diabetic population.
Currently, there are multiple assessment tools available to specialists in this area such as
orthopedics and podiatry but are far more advanced than what is needed for early
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recognition and referral for advanced practice nurses. After receiving feedback regarding
a need from local advanced practice nurses, an assessment and screening tool was
developed, along with screening algorithm and assessment and treatment practice
guidelines, as a means to assist them in the care of the diabetic patient population who are
at risk due to peripheral sensory deficits. In doing so, the goal is for immediate
intervention, treatment, and referral to podiatry specialty if warranted and prevent further
damage or injury.
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Appendix A: Computation of an S-CVI for a 10-Item Scale with Two Expert Raters

Expert Rater No 1 Expert Rater No 2
Items rated 1 or

Total

2

0

2

0

8

8

2

8

10

2
Items rated 3 or
4
Total
S-CVI 8/10 = .80

S-CVI, content validity index for the scale.
Ratings of 1 = not relevant
Ratings of 2 = somewhat relevant
Ratings of 3 = quite relevant
Ratings of 4 = highly relevant
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Appendix B: Charcot Foot Assessment and Screening Tool

Patient _________________________________
DOB________________Age________________
Diabetes Type ________Duration_______
PCP______________________________________

Management
Insulin____________________
Oral_______________________
Diet_______________________
Latest HgA1C_____________

Height________Weight________BMI______

Neuropathy Monofilament Testing Sites
Monofilament testing for diabetic neuropathy using preferred testing
locations colored green
If all sites are tested and the client feels the monofilament in each of the areas; then
the score is 10 /10

.
If the monofilament is not felt in an area on the foot, this indicates loss of
protective sensation (LOPS) in that area and requires referral to a podiatrist
SKIN
Turgor________________________________________Color__________________________________________
Temperature_________________________________Nails___________________________________________
Calluses_______________________________________Other__________________________________________
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SENSORY
RIGHT FOOT
Sensation: Present_______Absent__________
Numbness/Tingling
Yes____No_______
Burning
Yes____No______
Sharp Pain
Yes____No______

LEFT FOOT
Sensation: Present_____Absent_____
Numbness/Tingling Yes____No_____
Burning
Yes____No_____
Sharp Pain
Yes____No_____

VASCULAR
RIGHT FOOT
Pedal pulse: Present_______Absent_________
Edema: None____1+____2+____3+____4+____

LEFT FOOT
Pedal Pulse: Present____Absent_____
Edema: None___1+___2+__3+__4+__

WOUNDS
RIGHT FOOT
Ulcer Yes_____No_________
Description (approx. size in mm)
_____________________________________________
_____________________________________________

LEFT FOOT
Ulcer Yes____No________
Description (approx. size in mm)
_______________________________________
_______________________________________

DEFORMITIES
RIGHT FOOT
Bunion
Corns
Arch intact
Other

Yes_____No_________
Yes_____No_________
Yes_____No_________
_____________________

LEFT FOOT
Bunion
Corns
Arch intact
Other

Yes_____No_______
Yes_____No_______
Yes_____No_______
___________________

RISK LEVEL
Low Risk_______
No sensory loss, ulcerations, or deformities
Treatment: Annual Assessment
Moderate Risk________
Altered sensory, minimal structural deformity, or beginning onset of ulcerations
Treatment: Refer to Podiatry
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High Risk________
Impaired sensory, + numbness/tingling, healed or active ulcerations, amputation,
deformities
Treatment: Refer to Podiatry
REFERRAL
Name of Podiatrist_____________________________Date Contacted_____________________________
Person making referral________________________Appointment Date_________________________
Special instructions or treatment given by
podiatrist_____________________________________________________________________________________
Signature of
Provider_________________________________________Date________________________________________
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Appendix C: Charcot Foot Screening Algorithm

Charcot Foot Screening Algorithm
No
NO

History of erythema
or swelling

Yes
YES

Decreased or absent
pulses

ANNUAL
ASSESSMENT

Numbness or
tingling

REFER TO
PODIATRY

Deformities
Active or healed
ulcerations
Lab values (ESR, CRP) WNL
and
No Abnormal radiographic findings

Amputations

Abnormal lab (Elevated ESR, CRP)
and
Abnormal radiographic findings
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Appendix D: Charcot Foot Assessment and Treatment Practice Guidelines

The following areas have been identified as primary focus points to aid in the detection,
prevention, and treatment of Charcot foot in the diabetic patient population.

HISTORY





Edema or erythema
Impaired neurovascular symptoms
Recent injury or trauma
Previous foot ulceration or amputation

INSPECTION





Foot deformities or ulcerations
Erythema or blisters
Evidence of nonhealing areas
Dryness, cracking, calluses, or fungal infections

MONOFILAMENT TESTING
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 Recommended of four sites (1st, 3rd, and 5th metatarsal heads and plantar
surface of distal hallux) be tested on each foot
 Apply the monofilament along the perimeter of (not on) the ulcer site
 Apply the monofilament to each site three times, including at least one
additional
mock application in which no filament is applied
LABORATORY AND RADIOLOGIC TESTING
 ESR and CRP (Erythrocyte Sedimentation Rate and C-Reactive Protein)
 Radiologic exams on affected foot and ankle
TREATMENT OR REFERRAL





Offloading of affected foot (orthopedic boot)
Non weightbearing of affected foot (crutches)
Referral to podiatry if identified as at risk or abnormal findings
Annual foot examinations of no abnormal findings or risk factors identified
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Appendix E: Development of Assessment and Screening Tool

Development of Assessment and Screening Tool
to Assist with Prevention and Identification of Charcot Foot in Type 2 Diabetics
IMPLEMENTATION PLAN and EVALUATION PLAN
Goal: Promote patient safety, improve patient outcomes, and reduce the risk of infection,
deformity, amputation, or loss of life.
Objective

Strategy/Tasks

Stakeholder

Date to be
Completed

Evaluation
Status

1.Assemble an
interdisciplinary
project team
community of
stakeholders to guide
the project

Collaboration of experts
related to the treatment
of adult type 2 diabetic
patients, focusing on the
diabetic foot

Adult type 2
diabetic patient
population

October 1,
2015

Met

Adult type 2
diabetic patient
population

February 1,
2016

Met

March 1,
2016

Met

Contact individual team
members
2. Development of
assessment and
screening tool of the
diabetic foot

Collaborate with
members of the
interdisciplinary team for
development of the tool
Review various
assessment tools
currently being utilized
by healthcare
practitioners and
incorporate key
assessment areas as
recommended by team
experts as well as
American Diabetes
Association (ADA)
recommendations

3. Development of
assessment and
treatment algorithm

Collaborate with
members of the
interdisciplinary team for
development of the

Advanced practice
nurses

Adult type 2
patient population
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algorithm

Advanced practice
nurses

Follow ADA
recommendations for
treatment of Charcot foot
4. Development of
treatment and practice
guidelines

Collaborate with
members of the
interdisciplinary team for
development of
guidelines
Follow ADA
recommendations for
treatment of Charcot foot
and collaborate with
experts in the area of
policy and practice
guidelines

5. Present assessment
and screening tool,
algorithm, and
treatment and practice
guidelines to area
nurse practitioners

Power point and oral
presentation

6. Dissemination of
project tools

Electronic dissemination

Adult type 2
patient population

April 1, 2016

Met

Advanced practice
nurses

April 23,
2016

Met

Advanced practice
nurses

June 1, 2016

Not met

Advanced practice
nurses

December 1,
2016

Not met

Advanced practice
nurses

Present at annual nurse
practitioner conference

Email project tools
7. Evaluation of
project tools

Electronic survey
Email online survey link

